TSS:Hg 178626.1

Basic information about the TSS

---

TSS ID: hg_178626.1 Species: human Chr: chr19		Start: 6393434 End: 6393449 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: ENST00000595047.5 Distance: 230 GeneID: 2962 HGNC/MGI_ID: HGNC:4652 UniProt_ID: M0R0R9

Gene_name: general transcription factor IIF subunit 1 Gene_symbol: GTF2F1 Gene_synonyms: BTF4 RAP74 TF2F1 TFIIF Gene_source: HGNC:4652

TATA-Box annotation

---

Distance to TSS:	-278
Nearest PromoterID:	NM_002096
Entrez ID:	2962
Nearest Unigene:	Hs.68257
Nearest Refseq:	NM_002096
Nearest Ensembl:	ENSG00000125651
Gene Name:	general transcription factor IIF subunit 1
Gene Alias:	BTF4|RAP74|TF2F1|TFIIF
Gene Description:	general transcription factor IIF subunit 1
Gene Type:	protein-coding
CpG%:	0.07
GC%:	0.59204
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@GTF2F1 p2@GTF2F1 p3@GTF2F1 p4@GTF2F1 p5@GTF2F1 p6@GTF2F1 p8@GTF2F1
Sample		p1@GTF2F1	p2@GTF2F1	p3@GTF2F1	p4@GTF2F1	p5@GTF2F1	p6@GTF2F1	p8@GTF2F1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	67.79	19.68	8.38	2.14	3.51	0.97	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	70.20	18.01	8.30	2.02	7.08	0.61	0.61
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	77.55	20.64	9.07	1.35	6.75	0.96	0.19
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	72.35	18.71	7.07	1.46	9.15	1.25	1.04
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	69.06	16.87	6.75	1.12	10.12	1.57	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	69.77	12.60	9.30	1.74	6.01	1.74	0.19
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	88.02	17.43	15.25	1.09	8.06	1.96	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	69.03	17.44	10.17	0.97	9.69	0.24	0.48
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	79.50	19.66	13.89	1.92	8.55	1.07	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	106.07	23.19	21.45	1.16	27.24	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	101.87	21.42	19.81	1.21	22.23	1.62	1.62
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	112.62	24.80	14.64	1.63	14.23	2.44	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	84.30	9.19	1.45	0.97	0.16	0.32	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	77.73	7.22	2.26	0.90	0.60	0.00	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	85.19	5.05	1.32	1.10	1.10	0.44	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	74.94	7.04	1.51	1.26	0.25	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	73.82	8.30	1.09	0.66	0.00	0.00	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	77.19	7.59	2.11	0.84	0.00	0.42	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	71.98	7.46	2.67	2.13	1.07	1.60	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	82.44	6.62	2.11	1.35	0.30	0.15	0.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	78.72	5.48	2.41	0.80	0.40	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	79.41	6.39	2.93	0.35	0.35	0.00	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	72.13	6.85	1.94	1.29	0.26	0.26	0.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	69.89	6.07	0.97	0.73	0.49	0.24	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	84.10	8.00	1.55	0.26	0.26	0.52	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	87.99	9.18	3.17	1.27	0.32	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	69.23	12.09	2.20	1.65	1.10	1.65	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	87.70	9.90	2.83	2.12	0.71	1.41	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	67.36	6.14	2.42	1.45	0.32	0.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	80.89	7.96	1.45	0.72	0.00	0.54	0.18
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	79.34	7.96	2.51	0.63	0.21	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	86.75	7.42	2.74	0.20	0.39	1.56	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	66.05	6.12	2.32	0.63	0.84	0.21	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	77.03	7.42	2.31	0.33	0.49	0.82	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	77.97	8.41	2.06	0.56	0.00	0.56	0.37
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	63.62	9.39	2.30	0.77	0.19	0.38	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	73.58	10.42	2.04	1.64	0.41	0.61	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	60.45	7.05	2.01	0.81	0.20	0.40	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	78.06	8.37	2.70	0.54	0.27	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	72.74	7.68	3.36	1.44	0.48	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	64.46	11.06	1.18	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	65.58	9.08	2.64	1.61	0.59	1.02	0.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	66.85	9.28	2.32	1.27	0.42	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	61.01	8.22	1.57	1.22	1.05	0.17	0.17
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	72.28	7.23	4.22	1.81	0.00	1.00	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	75.14	9.54	2.09	0.93	0.23	1.16	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	60.46	8.88	1.68	1.44	0.00	0.96	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	61.10	9.24	5.07	2.09	0.60	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	55.06	12.69	1.44	1.44	0.48	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	61.67	8.29	4.25	1.42	0.81	0.81	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	106.17	21.11	3.28	1.84	0.00	1.02	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	115.19	21.57	3.56	2.22	0.67	0.44	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	153.91	13.99	13.99	0.00	0.00	13.99	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	110.01	12.77	1.77	1.77	0.71	0.35	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	105.71	18.89	1.99	2.32	0.33	0.33	0.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	71.31	11.75	6.71	0.84	0.00	1.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	94.14	13.78	5.97	1.84	0.46	0.46	0.46
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	112.79	10.37	2.27	2.59	0.65	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	110.16	20.55	1.61	2.57	0.64	0.96	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	144.59	22.95	4.09	0.94	0.31	0.31	0.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	113.51	8.46	2.82	0.71	0.71	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	92.53	13.46	2.80	1.12	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	103.50	13.53	2.39	0.00	1.59	1.59	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	106.01	17.67	4.42	1.70	0.00	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	107.87	14.30	1.30	2.27	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	104.36	12.42	2.13	2.13	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	80.82	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	157.95	23.69	7.90	7.90	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	70.20	13.16	4.39	1.46	0.98	0.49	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	76.86	12.40	1.98	0.50	0.50	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	66.15	15.48	1.88	1.88	0.94	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	89.42	18.22	1.32	1.99	0.66	0.33	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	82.59	14.54	0.93	2.17	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	81.33	12.84	1.22	1.22	0.00	0.00	0.00
Adipocyte - breast, donor1	11376-118A8	38.01	9.34	3.96	1.58	0.79	0.95	0.32
Adipocyte - breast, donor2	11327-117E4	36.90	10.43	3.53	2.09	0.96	0.64	0.00
Adipocyte - omental, donor1	11473-119C6	34.86	10.56	4.07	2.42	0.64	0.89	0.13
Adipocyte - omental, donor2	11474-119C7	35.88	7.47	1.49	3.74	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	53.59	7.03	2.01	1.67	1.34	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	51.04	3.19	2.55	0.64	0.00	0.64	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	32.99	3.30	1.10	0.00	1.10	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	39.29	9.03	4.06	1.35	1.81	0.90	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	53.00	4.52	1.04	0.52	0.52	0.35	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	30.70	7.04	1.37	0.78	0.39	0.78	0.00
Adipocyte differentiation, day04, donor2	13022-139D7	42.47	9.78	1.54	1.80	0.51	0.51	0.00
Adipocyte differentiation, day04, donor3	13025-139E1	46.56	7.81	3.07	1.12	0.84	0.56	0.00
Adipocyte differentiation, day04, donor4	13028-139E4	51.73	8.82	2.35	1.18	0.00	0.59	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	36.44	7.08	2.25	1.29	0.00	0.64	0.16
Adipocyte differentiation, day08, donor2	13023-139D8	47.44	8.07	2.26	0.32	0.65	0.65	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	39.99	4.80	3.73	0.53	0.53	0.00	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	53.42	10.57	1.11	1.11	1.11	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	32.02	10.81	2.91	0.83	0.00	0.42	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	39.43	8.04	1.00	1.51	0.75	0.00	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	29.45	10.80	1.31	1.64	0.00	0.65	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	32.58	9.74	1.83	0.30	0.30	0.61	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	83.98	16.13	7.07	3.76	3.54	1.10	0.44
Alveolar Epithelial Cells, donor2	11590-120G6	109.01	11.83	5.02	2.15	2.51	2.15	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	73.08	7.19	2.40	0.00	3.59	2.40	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	32.92	9.89	4.14	1.98	1.08	1.62	0.72
Amniotic Epithelial Cells, donor2	11613-122A2	55.23	5.02	5.02	5.02	1.67	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	67.80	12.94	3.90	4.31	0.41	1.03	0.21
Anulus Pulposus Cell, donor1	11248-116E6	85.36	7.78	3.66	2.29	0.34	1.03	0.69
Anulus Pulposus Cell, donor2	11463-119B5	87.19	5.39	2.69	1.22	0.00	0.98	0.49
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	58.41	7.19	4.04	2.70	1.35	0.45	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	61.21	9.99	4.34	3.04	0.43	2.17	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	34.24	12.84	2.14	2.14	0.00	2.14	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	54.40	9.57	4.18	1.49	0.30	0.30	0.90
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	50.59	10.12	2.53	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	56.11	7.92	4.62	2.64	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	40.29	7.80	5.20	0.97	0.97	0.32	1.30
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	53.88	10.68	1.46	1.94	0.49	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	71.86	8.31	2.97	2.38	0.00	1.78	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	55.74	10.17	1.88	2.26	1.13	0.75	0.38
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	54.43	7.98	2.18	0.73	0.00	0.73	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	43.88	13.79	2.51	1.25	1.25	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.22	5.93	2.97	1.65	0.66	0.33	0.16
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	36.85	4.09	4.09	2.73	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	36.94	11.31	2.11	1.66	0.90	0.15	0.45
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	48.76	12.86	2.68	3.75	2.14	1.07	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	49.88	9.45	2.83	1.70	0.76	0.94	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	66.29	10.16	3.74	2.41	1.60	0.80	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	46.82	6.83	2.93	1.95	0.98	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	51.08	8.62	1.99	1.82	0.66	0.50	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	60.04	14.41	3.60	0.00	3.60	2.40	1.20
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	38.94	14.16	0.00	10.62	3.54	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	59.01	8.75	2.92	1.20	0.69	0.34	0.69
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	0.00	4.19	0.00	4.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	65.05	8.25	3.88	1.94	0.49	0.49	0.49
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	59.57	6.07	2.28	0.00	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	71.47	12.11	6.06	1.21	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	49.02	4.56	1.71	1.14	0.57	0.57	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	49.38	9.62	2.35	1.71	1.50	1.07	0.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	60.91	13.68	1.29	2.58	1.81	0.77	0.52
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	52.08	8.45	1.41	2.82	0.94	1.41	0.47
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	47.59	10.61	0.96	1.61	1.29	1.29	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	68.49	12.13	3.57	2.14	2.14	0.71	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	46.80	5.26	3.51	0.00	1.17	1.75	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	66.54	10.54	2.41	2.71	0.30	0.30	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	62.96	9.50	1.19	2.38	0.00	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	54.42	10.17	6.61	1.02	1.02	0.51	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	57.30	11.46	2.80	2.04	0.51	0.25	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	50.19	6.99	1.27	0.64	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	55.24	6.04	3.88	2.16	0.43	1.29	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	52.50	10.37	1.69	1.48	0.85	0.21	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	58.87	10.15	3.19	1.45	2.03	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	64.24	12.28	4.72	0.00	0.94	0.00	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	48.99	7.12	2.37	2.03	0.68	0.34	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	76.44	9.27	6.95	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	50.70	14.79	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	60.89	8.36	2.79	0.64	0.21	0.86	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	69.79	13.84	1.80	3.01	0.60	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	43.74	7.29	5.10	0.73	1.46	0.00	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	49.65	11.03	4.14	1.38	0.46	0.23	0.69
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	73.96	10.20	2.55	5.10	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	34.07	8.90	2.03	1.27	1.27	0.76	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	58.22	10.12	3.72	2.06	1.24	1.03	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	63.95	11.02	4.28	2.75	0.61	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	50.67	8.13	2.87	3.82	0.96	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	55.66	9.31	3.10	1.55	2.44	1.33	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	68.66	7.63	3.05	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	53.73	11.63	2.77	1.11	2.22	0.55	0.55
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	42.37	7.41	4.77	1.06	2.12	1.59	0.26
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	64.33	7.27	4.00	0.73	2.18	0.73	0.00
Astrocyte - cerebellum, donor1	11500-119F6	78.73	12.16	10.19	2.70	1.97	2.82	0.98
Astrocyte - cerebellum, donor2	11580-120F5	95.51	11.64	5.48	2.74	0.68	1.88	0.34
Astrocyte - cerebellum, donor3	11661-122F5	66.91	10.70	6.71	1.68	1.68	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	65.53	11.50	7.67	0.70	1.39	1.05	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	71.34	11.49	5.66	1.29	0.65	1.29	0.81
Astrocyte - cerebral cortex, donor3	11392-118C6	43.41	8.50	5.67	2.09	1.04	0.45	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	103.22	21.45	11.81	4.70	1.49	1.83	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	118.77	28.69	14.53	5.39	3.76	2.38	0.63
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	106.74	26.51	12.06	5.69	2.73	1.59	0.80
Basophils, donor1	12241-129G9	52.05	7.85	10.46	2.62	7.32	0.26	0.00
Basophils, donor2	12242-129H1	81.54	15.15	10.82	2.89	9.74	1.44	0.00
Basophils, donor3	12243-129H2	47.48	6.32	5.14	2.20	3.53	0.44	0.00
Bronchial Epithelial Cell, donor1	11511-119G8	31.91	9.06	2.80	0.86	1.08	0.65	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	42.98	10.97	3.20	1.37	0.00	0.91	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	50.21	28.69	7.17	0.00	7.17	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	52.72	8.79	4.39	1.88	2.51	1.26	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	60.93	10.61	5.41	2.29	1.66	1.04	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	39.15	5.76	3.68	2.07	0.46	0.23	0.23
Bronchial Epithelial Cell, donor7	11769-123I5	47.69	10.44	3.06	1.80	0.54	0.54	0.36
Burkitt's lymphoma cell line:DAUDI	10422-106C8	50.91	4.12	11.75	1.44	4.02	1.85	0.62
Burkitt's lymphoma cell line:RAJI	10476-106I8	39.13	5.12	9.55	1.40	2.33	2.33	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	79.62	4.80	9.59	2.88	3.52	0.64	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	31.03	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	46.21	6.76	3.94	1.69	5.64	0.56	0.00
CD14+ Monocytes, donor2	11305-117B9	66.63	10.02	6.31	1.67	2.78	0.19	0.00
CD14+ Monocytes, donor3	11381-118B4	53.35	8.34	6.81	1.76	7.03	1.10	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	72.18	15.57	2.83	3.68	0.57	0.57	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	61.41	17.44	0.00	3.79	1.52	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	64.10	10.52	3.29	4.60	1.64	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	61.87	10.99	4.34	2.02	3.47	0.58	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	46.77	8.45	4.53	2.11	2.41	0.00	0.30
CD14+ monocytes - mock treated, donor3	11883-125D2	50.93	9.95	6.63	2.84	6.63	0.00	0.24
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	42.52	8.20	7.20	2.34	4.18	0.50	0.00
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	46.37	6.35	1.66	1.38	2.76	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	37.44	8.93	3.97	1.74	6.45	0.50	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	33.68	9.99	6.07	2.15	3.72	0.39	0.00
CD14+ monocytes - treated with BCG, donor2	11870-125B7	38.46	7.83	4.63	1.25	3.56	0.53	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	37.43	7.40	5.22	2.18	4.13	0.65	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	39.33	6.32	4.92	2.11	5.38	0.47	0.00
CD14+ monocytes - treated with Candida, donor2	11878-125C6	62.31	11.62	2.64	2.11	4.22	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	45.48	11.09	3.33	2.22	13.31	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	47.15	10.71	5.50	1.93	4.31	0.59	0.15
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	52.48	9.18	2.79	1.00	2.59	0.20	0.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	37.89	7.70	6.45	2.29	6.04	1.46	0.21
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	42.10	8.92	8.24	3.66	5.72	0.69	0.00
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	32.80	7.69	4.07	2.04	4.98	0.45	0.23
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	32.30	8.29	3.93	1.31	9.60	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	49.23	6.19	4.30	1.34	1.88	0.27	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	59.49	10.64	3.14	4.01	2.44	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	55.97	14.31	5.05	5.05	2.95	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	30.86	6.80	3.49	1.29	5.33	0.37	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	27.12	8.10	2.11	1.06	3.87	0.35	0.00
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	25.45	6.58	5.70	2.19	3.95	0.88	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	32.08	6.28	3.66	0.52	4.18	0.52	0.17
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	40.14	13.38	3.72	0.00	1.86	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	40.74	7.54	11.21	2.37	7.98	0.43	0.22
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	36.44	10.24	3.69	2.46	6.14	0.41	0.41
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	29.67	6.49	2.78	0.93	5.10	0.70	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	26.45	9.51	4.18	1.39	7.66	0.23	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	31.82	9.59	5.89	3.49	1.74	0.44	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	39.04	8.55	1.85	2.77	1.39	0.46	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	32.49	9.53	6.07	1.52	3.68	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	60.26	10.43	5.76	2.18	2.49	0.31	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	47.33	9.95	4.37	0.87	2.10	0.17	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	57.08	9.81	6.24	2.01	3.12	0.22	0.00
CD14-CD16+ Monocytes, donor1	11790-124B8	29.35	6.89	7.14	2.81	6.38	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	29.20	7.47	2.85	3.51	2.85	1.10	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	36.21	9.69	6.11	2.11	6.11	0.21	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	69.10	4.06	4.06	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	61.02	8.14	3.39	0.68	0.68	0.68	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	69.39	7.25	3.11	4.14	0.00	1.04	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	44.24	4.26	3.20	1.07	0.53	1.07	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	76.66	8.58	2.68	1.61	0.54	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	63.17	8.42	4.91	0.70	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	57.26	8.63	1.57	0.78	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	88.33	3.95	2.64	2.64	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	84.66	16.44	12.33	2.47	6.58	0.00	0.82
CD19+ B Cells, donor2	11624-122B4	72.54	13.78	13.06	2.90	5.80	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	67.65	6.06	15.65	3.53	5.05	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	68.29	56.16	28.69	11.31	5.66	4.85	2.42
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	53.53	43.15	19.18	5.99	8.79	1.20	0.80
CD34+ Progenitors, donor1	11545-120B6	56.23	9.04	7.03	2.01	3.01	1.00	0.00
CD34+ Progenitors, donor2	11625-122B5	87.64	2.81	14.61	1.12	3.93	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	45.09	4.51	8.27	0.38	3.76	0.00	0.38
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	54.34	6.31	7.89	1.13	4.28	1.58	0.00
CD4+ T Cells, donor1	11225-116C1	122.83	10.71	26.07	1.79	32.85	0.71	0.00
CD4+ T Cells, donor2	11306-117C1	110.23	9.19	29.39	1.22	18.37	1.22	0.61
CD4+ T Cells, donor3	11382-118B5	97.60	7.32	17.38	1.52	16.47	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	55.13	10.46	2.55	1.53	1.28	0.26	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	76.14	16.17	1.80	1.35	0.22	0.22	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	77.90	15.81	2.59	4.02	0.29	0.29	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	74.91	8.53	17.54	1.42	6.64	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	76.55	9.83	15.45	2.11	5.62	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	92.29	3.30	3.30	0.00	3.30	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	61.13	11.42	3.03	1.45	1.45	0.43	0.29
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	98.12	18.47	2.88	2.37	0.51	0.17	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	93.50	17.89	2.42	2.74	0.64	0.00	0.16
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	55.14	7.62	6.72	1.79	3.59	0.45	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	53.46	8.73	6.29	2.10	3.84	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	79.20	12.32	8.80	1.76	5.28	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	67.88	9.28	4.22	0.42	0.00	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	104.92	20.15	3.53	2.29	0.62	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	112.94	18.04	1.67	2.34	1.00	0.67	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	84.57	9.25	16.04	0.54	6.25	1.09	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	84.14	11.79	18.22	1.07	4.29	1.07	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	111.18	16.14	10.76	1.79	3.59	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	77.51	17.24	3.52	2.97	0.74	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	56.54	11.26	2.17	1.52	0.65	0.00	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	73.13	13.45	3.78	1.05	0.42	0.21	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	52.08	3.54	10.62	3.03	12.13	1.52	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	62.82	8.23	13.43	2.60	7.37	0.87	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	88.03	13.51	14.38	1.74	7.41	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	83.63	14.35	5.94	0.49	0.49	0.99	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	84.93	12.00	1.85	0.92	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	72.58	8.37	2.79	4.19	1.40	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	103.85	10.80	5.26	3.32	1.94	0.55	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	109.94	11.53	5.40	2.45	1.23	1.23	0.25
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	97.02	10.78	4.62	3.08	0.00	1.54	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	93.47	14.32	6.80	1.79	1.07	0.72	0.36
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	101.10	13.85	1.38	4.15	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	58.93	6.88	21.61	1.31	30.78	0.65	0.00
CD8+ T Cells, donor2	11307-117C2	92.36	10.14	20.65	2.63	21.78	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	91.91	11.36	22.22	4.04	26.26	0.25	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	42.21	15.37	2.52	1.61	1.15	0.23	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	43.14	14.86	3.83	0.96	1.68	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	41.59	11.49	2.74	1.64	2.74	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	44.13	17.11	3.90	1.50	2.10	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	28.56	7.68	1.44	1.68	0.96	0.00	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	39.34	12.28	2.73	1.59	1.36	0.68	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	45.41	10.65	2.17	0.65	1.09	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	47.64	13.95	1.84	1.05	0.53	0.79	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	41.98	12.90	3.05	2.11	2.11	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	51.62	13.89	1.81	1.21	1.51	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	47.93	14.23	2.91	1.74	2.32	0.00	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	39.17	10.12	3.46	0.53	2.40	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	42.90	11.38	1.31	1.31	8.32	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	35.07	8.20	2.73	2.28	10.47	0.00	0.00
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	32.07	6.71	0.75	2.98	10.44	0.75	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	39.26	9.00	3.24	2.52	2.88	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	40.28	13.24	3.16	0.86	0.29	0.00	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	40.30	12.02	2.83	0.47	1.89	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	38.66	11.73	1.90	1.90	1.90	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	38.45	15.99	1.54	0.92	0.31	0.00	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	37.51	11.86	1.92	0.32	1.60	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	31.74	14.15	2.29	2.29	2.29	0.00	0.38
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	32.32	11.82	2.76	1.58	0.79	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	35.55	14.37	0.00	1.51	0.76	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	44.16	17.67	3.21	2.41	21.68	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	62.95	14.69	2.10	2.80	25.88	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	50.09	12.02	1.00	2.00	21.04	0.00	0.00
Cardiac Myocyte, donor1	11525-119I4	146.22	5.48	5.48	5.48	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	53.86	8.40	3.95	0.49	0.99	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	48.09	8.21	4.31	1.79	0.53	1.16	0.21
Chondrocyte - de diff, donor1	11261-116G1	83.89	16.99	6.24	3.47	0.69	1.73	0.35
Chondrocyte - de diff, donor2	11338-117F6	20.97	3.91	3.55	0.71	0.71	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	47.79	7.62	3.07	1.48	1.02	0.91	0.57
Chondrocyte - re diff, donor2	11339-117F7	29.54	12.53	4.48	0.90	2.69	0.90	0.00
Chondrocyte - re diff, donor3	11411-118E7	43.27	5.26	3.24	0.81	1.21	0.40	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	71.61	9.18	7.34	1.84	1.38	1.38	0.92
Ciliary Epithelial Cells, donor2	11323-117D9	53.44	8.55	7.27	2.57	2.14	0.64	1.28
Ciliary Epithelial Cells, donor3	11399-118D4	58.76	7.79	6.90	1.50	1.68	1.33	0.44
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	81.61	20.54	9.90	4.22	1.65	3.30	4.22
Corneal Epithelial Cells, donor1	11526-119I5	49.62	14.05	5.49	0.66	0.44	1.10	0.44
Corneal Epithelial Cells, donor2	11606-120I4	68.26	5.69	7.96	3.41	1.14	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	46.01	13.04	4.35	2.30	1.02	1.02	0.51
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	35.66	11.89	2.31	2.31	0.00	0.50	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	27.13	10.41	0.63	2.21	0.00	0.32	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	31.06	6.90	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	32.29	11.01	2.16	2.27	1.08	0.54	0.00
Dendritic Cells - plasmacytoid, donor1	11228-116C4	44.07	14.35	6.49	1.71	3.07	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	63.98	8.49	6.53	2.61	1.96	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	71.14	9.68	4.84	3.87	3.39	1.94	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	49.36	7.84	4.00	1.33	0.83	0.83	0.17
Endothelial Cells - Aortic, donor1	11263-116G3	35.21	8.21	2.35	2.35	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	48.64	7.64	3.68	1.70	0.00	0.28	0.28
Endothelial Cells - Aortic, donor3	11412-118E8	55.44	6.29	2.36	1.18	0.39	0.00	0.39
Endothelial Cells - Artery, donor1	11264-116G4	43.63	9.89	4.65	1.75	0.29	0.87	0.58
Endothelial Cells - Artery, donor2	11341-117F9	57.41	12.23	3.29	3.29	0.94	0.94	0.47
Endothelial Cells - Artery, donor3	11413-118E9	46.98	8.41	2.80	1.40	1.75	0.35	0.35
Endothelial Cells - Lymphatic, donor1	11236-116D3	46.10	5.10	0.89	1.33	0.89	0.44	0.00
Endothelial Cells - Lymphatic, donor2	11317-117D3	43.81	6.39	1.83	1.83	0.61	0.61	0.30
Endothelial Cells - Lymphatic, donor3	11393-118C7	36.37	4.51	1.41	1.13	0.56	0.00	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	62.40	6.24	2.67	1.49	0.30	0.30	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	29.16	3.64	3.12	1.56	0.00	0.52	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	42.82	5.10	1.13	0.43	0.57	0.28	0.00
Endothelial Cells - Thoracic, donor1	11266-116G6	70.02	7.60	3.60	1.20	2.40	0.80	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	72.85	13.10	2.62	1.57	0.00	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	64.11	8.45	2.73	0.99	0.99	0.75	0.12
Endothelial Cells - Umbilical vein, donor2	11324-117E1	78.43	7.17	1.30	1.96	0.87	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	76.94	9.89	2.20	2.69	0.12	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	36.40	6.83	1.14	0.00	0.00	3.41	0.00
Endothelial Cells - Vein, donor2	11344-117G3	46.80	10.48	4.89	0.70	0.70	2.10	0.00
Endothelial Cells - Vein, donor3	11416-118F3	32.03	5.02	3.14	1.88	1.10	0.63	0.16
Eosinophils, donor1	12244-129H3	106.73	0.00	0.00	0.00	15.25	0.00	0.00
Eosinophils, donor2	12245-129H4	66.01	19.80	14.85	3.30	8.25	0.00	0.00
Eosinophils, donor3	12246-129H5	39.24	14.27	10.70	3.57	7.13	10.70	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	41.54	10.51	3.66	2.44	0.73	0.98	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	43.68	2.08	2.08	2.08	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	48.81	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	40.64	6.57	1.23	2.46	0.00	0.00	0.00
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	18.18	6.79	1.64	0.99	0.66	0.22	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	30.98	6.50	3.14	1.08	0.65	0.76	0.22
Fibroblast - Aortic Adventitial, donor1	11245-116E3	37.48	10.07	5.94	1.58	1.09	1.09	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	37.80	15.56	9.69	4.09	4.91	2.46	0.82
Fibroblast - Aortic Adventitial, donor2	11326-117E3	36.91	9.28	3.90	1.90	0.32	0.95	0.32
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	37.68	10.80	11.86	2.90	3.16	3.43	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	33.88	7.64	5.65	2.66	1.00	1.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	50.81	8.17	3.63	1.36	1.81	0.45	0.45
Fibroblast - Cardiac, donor2	11345-117G4	37.90	8.34	3.03	1.52	1.52	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	41.32	8.20	2.84	1.73	1.10	0.47	0.16
Fibroblast - Cardiac, donor4	11452-119A3	51.23	9.09	5.46	1.21	0.61	0.91	0.00
Fibroblast - Cardiac, donor5	11456-119A7	76.02	7.99	3.30	1.90	0.76	0.63	0.38
Fibroblast - Cardiac, donor6	11460-119B2	61.40	10.31	5.46	1.67	0.91	0.61	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	65.25	6.97	6.16	2.95	1.34	2.01	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	40.55	6.47	4.75	0.86	0.43	0.43	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	58.59	14.65	0.00	0.00	0.00	1.46	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	90.41	14.76	7.61	5.07	1.38	1.61	0.92
Fibroblast - Conjunctival, donor3	11692-122I9	77.34	7.29	7.97	1.02	0.51	1.53	0.17
Fibroblast - Dermal, donor1	11269-116G9	37.10	9.39	1.88	1.88	0.23	0.94	0.23
Fibroblast - Dermal, donor2	11346-117G5	39.15	11.32	5.66	2.36	1.89	1.42	0.47
Fibroblast - Dermal, donor3	11418-118F5	38.68	9.31	4.59	2.30	0.73	0.85	0.12
Fibroblast - Dermal, donor4	11450-119A1	57.54	10.17	3.39	2.60	0.34	0.45	0.00
Fibroblast - Dermal, donor5	11454-119A5	78.68	11.51	3.66	2.79	0.52	0.70	0.17
Fibroblast - Dermal, donor6	11458-119A9	83.16	12.51	5.04	2.92	0.97	1.14	0.32
Fibroblast - Gingival, donor1	11237-116D4	54.56	10.20	6.87	1.67	1.67	0.83	0.21
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	46.37	13.10	4.72	3.67	1.31	1.05	0.00
Fibroblast - Gingival, donor2	11318-117D4	62.86	11.07	3.95	1.71	0.92	1.98	0.26
Fibroblast - Gingival, donor3	11394-118C8	72.61	8.99	3.00	2.03	0.77	0.87	0.48
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	34.28	6.23	3.12	1.04	1.04	1.04	1.04
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	33.48	7.58	2.47	0.53	0.35	0.35	0.35
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	56.43	14.19	6.55	3.12	1.09	0.62	0.47
Fibroblast - Gingival, donor6 (control)	11922-125H5	44.49	14.88	4.87	3.38	1.35	0.95	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	21.88	8.47	3.18	2.12	1.06	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	60.84	20.18	4.97	3.36	1.17	1.17	0.15
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	43.77	17.45	4.36	3.55	2.05	0.82	0.14
Fibroblast - Gingival, donor8 (control)	11926-125H9	44.86	18.21	6.47	3.18	1.32	1.76	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	38.89	7.19	3.37	1.47	0.00	0.29	0.00
Fibroblast - Lung, donor1	11270-116H1	29.91	5.44	5.44	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	46.26	8.95	4.48	4.48	0.00	2.98	1.49
Fibroblast - Lung, donor3	11419-118F6	57.40	10.97	5.49	1.48	0.00	1.06	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	101.63	21.66	6.66	5.00	0.00	0.00	0.83
Fibroblast - Lymphatic, donor2	11586-120G2	74.13	8.39	1.40	1.40	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	41.70	7.84	3.36	0.56	0.00	0.84	0.28
Fibroblast - Mammary, donor1	11540-120B1	64.96	23.55	6.90	4.06	1.22	2.44	0.41
Fibroblast - Mammary, donor2	11620-122A9	83.88	31.95	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	11.91	29.78	0.00	5.96	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	51.21	13.19	4.27	1.36	1.36	1.75	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	57.64	14.11	6.98	2.73	0.46	1.21	0.30
Fibroblast - Periodontal Ligament, donor3	11395-118C9	47.12	16.22	5.20	2.45	1.22	0.92	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	41.22	11.83	3.82	3.05	0.38	0.76	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	42.66	9.18	5.13	3.24	0.54	1.62	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	40.94	7.65	1.62	1.86	0.23	0.58	0.23
Fibroblast - Pulmonary Artery, donor1	11250-116E8	48.19	10.28	5.64	1.88	1.33	0.99	0.00
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	69.29	21.34	8.53	1.42	1.63	2.24	1.22
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	79.52	15.37	8.02	3.34	0.67	0.67	0.67
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	54.16	12.26	6.33	0.40	0.00	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	71.84	19.65	14.49	3.18	2.38	3.37	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	37.12	7.64	5.33	1.78	1.42	1.07	0.36
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	35.48	8.08	3.74	1.77	1.18	0.59	0.20
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	71.60	18.95	14.44	2.41	3.91	2.41	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	58.51	10.47	7.02	1.94	0.54	1.08	0.76
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	56.44	17.97	8.60	4.81	2.78	2.53	1.77
Fibroblast - skin normal, donor1	11553-120C5	40.36	10.34	5.74	1.48	1.31	0.98	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	62.16	25.46	11.83	2.41	2.41	2.61	1.20
Fibroblast - skin normal, donor2	11561-120D4	59.47	10.25	6.43	2.61	0.70	1.71	0.30
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	82.21	15.72	16.62	4.84	3.32	3.02	1.21
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	63.21	8.37	7.21	2.15	0.75	0.75	0.33
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	101.89	7.18	10.77	3.25	1.03	2.22	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	77.51	16.75	14.12	4.27	4.60	3.28	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	63.17	12.78	6.50	2.13	1.17	1.60	0.21
Fibroblast - skin walker warburg, donor1	11554-120C6	58.03	15.52	7.59	2.19	1.86	0.67	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	36.38	8.15	5.02	1.73	0.31	0.94	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	155.12	22.16	0.00	0.00	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	54.03	8.72	0.87	1.74	0.87	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	31.20	10.23	2.77	1.91	1.56	1.21	0.17
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	29.15	11.71	3.38	1.04	1.30	0.52	0.52
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	26.32	10.22	3.07	1.53	0.51	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	98.76	4.59	5.36	0.77	2.30	1.53	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	102.09	3.19	3.19	0.00	2.55	1.91	0.64
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	123.52	5.13	5.99	0.86	3.99	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	128.23	7.17	3.86	1.10	1.10	0.55	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	100.46	8.22	1.60	0.68	0.46	0.46	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	116.30	3.96	4.76	0.59	1.78	0.40	0.40
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	110.76	4.23	2.64	0.53	1.32	0.53	0.53
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	117.09	7.83	3.26	1.30	0.98	1.30	0.65
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	99.50	5.31	3.10	0.44	3.54	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	60.20	3.53	2.97	0.28	1.13	0.99	0.99
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	62.43	3.94	4.68	0.12	1.85	1.35	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	61.25	4.30	2.95	0.27	1.88	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	61.82	2.11	4.46	0.74	0.74	0.50	0.37
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	57.03	2.35	5.54	0.00	1.66	1.25	0.55
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	60.99	3.05	4.07	0.81	1.22	1.02	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	67.31	4.56	6.16	0.91	0.46	1.60	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	61.54	2.74	3.24	0.62	1.25	0.87	0.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	55.96	4.81	3.06	0.22	0.87	0.22	1.09
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	72.69	6.21	5.91	1.77	1.48	0.30	0.30
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	61.68	2.70	5.25	0.79	0.95	0.79	0.32
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	50.94	4.69	5.36	1.12	1.12	0.89	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	69.97	5.04	5.04	0.40	2.02	1.41	0.20
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	67.01	5.94	6.96	1.02	1.53	0.85	0.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	63.67	5.32	6.65	0.53	2.57	1.68	0.09
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	79.71	4.58	10.09	0.62	1.25	1.25	0.83
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	64.89	4.27	7.68	0.51	0.85	1.37	1.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	68.27	4.54	6.31	1.22	1.00	1.22	0.89
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	60.65	4.83	7.32	0.92	2.08	1.41	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	46.55	4.29	6.53	0.82	2.04	1.43	0.20
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	67.87	5.16	7.43	0.21	1.24	0.41	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	67.68	3.69	5.88	1.27	1.61	1.04	0.46
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	60.54	4.50	4.50	0.33	1.17	1.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	64.37	5.51	5.29	0.88	1.10	0.66	0.44
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	69.98	6.27	8.24	1.11	1.48	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	61.11	5.35	6.00	1.62	2.11	1.30	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	82.74	7.06	7.38	0.64	2.89	0.32	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	59.13	4.93	4.36	1.23	1.52	1.14	0.47
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	60.27	4.43	4.27	0.79	0.79	1.11	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	72.37	6.08	5.78	1.22	3.04	0.91	0.61
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	51.96	6.48	7.42	1.15	1.25	0.94	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	55.11	4.61	3.29	0.22	0.44	0.66	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	50.22	8.70	6.45	0.84	1.68	1.40	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	48.52	5.83	7.04	1.02	1.57	1.67	0.74
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	50.54	6.69	4.81	1.07	1.60	0.53	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	57.84	9.03	8.26	1.68	1.68	1.84	0.31
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	48.19	8.81	5.96	1.55	1.68	0.78	0.39
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	57.20	7.05	2.98	0.27	0.81	0.27	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	58.99	9.22	6.82	1.66	0.74	0.55	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	64.48	7.24	7.02	1.10	1.97	1.10	0.44
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	88.27	2.98	3.97	0.99	2.98	1.98	0.99
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	61.87	6.99	9.10	1.98	1.45	1.06	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	51.45	8.88	6.66	2.62	1.61	0.61	0.61
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	70.91	3.56	7.62	0.76	1.27	1.02	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	72.26	2.59	4.78	0.60	2.59	1.79	0.80
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	57.93	5.70	3.85	0.62	2.00	0.31	0.15
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	71.81	3.07	6.55	0.41	1.43	1.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	41.62	2.50	3.44	0.31	2.82	0.63	0.63
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	40.12	2.26	3.96	0.00	1.70	0.28	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	43.35	2.31	1.38	0.46	0.46	0.00	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	51.97	2.47	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	59.96	6.19	6.19	0.77	2.32	1.55	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	44.93	6.42	4.81	0.00	1.60	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	53.90	1.74	3.48	0.00	3.48	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	51.43	4.56	4.88	0.33	0.98	0.65	1.30
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	58.89	4.53	3.29	0.00	2.88	1.24	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	49.98	0.00	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	46.98	5.03	3.64	0.84	1.40	1.12	0.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	67.00	3.27	5.23	0.00	2.61	0.33	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	41.94	2.52	2.52	0.00	0.84	0.84	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	68.39	4.13	5.09	1.27	0.00	1.59	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	59.78	3.06	4.08	0.00	1.70	1.36	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	27.15	2.09	4.18	0.00	2.09	2.09	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	63.00	2.86	1.72	0.57	1.15	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	63.04	3.26	4.44	0.30	0.89	1.78	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	38.97	1.69	1.69	0.00	3.39	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	66.27	5.38	8.28	0.41	0.41	0.83	0.83
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	62.13	5.29	6.67	0.23	2.30	0.69	0.23
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	42.15	0.00	0.00	5.27	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	45.75	4.61	4.23	0.77	0.38	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	69.43	2.93	5.87	0.33	0.98	0.65	0.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	40.80	3.34	2.68	0.00	0.67	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	69.35	2.31	4.62	1.16	1.16	1.16	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	85.93	4.45	6.50	0.34	3.77	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	52.18	0.00	7.45	0.00	0.00	0.00	2.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	109.94	3.77	5.19	0.94	2.36	1.42	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	64.57	3.62	5.43	0.60	0.60	1.21	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	65.62	2.03	1.02	0.00	0.51	2.03	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	60.62	4.79	3.19	0.00	1.60	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	79.92	2.96	3.95	0.00	0.99	1.48	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	51.94	5.90	2.36	0.00	2.36	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	57.76	1.75	5.83	0.00	1.17	1.17	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	72.85	3.95	7.02	1.76	1.32	0.44	0.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	50.86	7.63	0.85	0.00	3.39	1.70	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	33.43	3.58	1.19	0.00	0.00	1.19	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	49.01	3.88	3.88	0.00	2.43	0.97	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	28.53	10.27	3.42	1.14	3.42	0.00	1.14
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	56.14	10.40	4.16	3.33	1.66	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	29.24	13.49	5.62	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	52.65	10.15	6.66	1.27	1.90	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	46.79	11.70	2.09	2.92	0.84	0.42	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	40.15	12.42	4.06	2.20	0.81	0.46	0.46
Hep-2 cells mock treated, biol_rep2	11899-125E9	33.76	12.83	3.71	2.87	1.18	0.51	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	27.98	14.56	3.64	2.96	1.37	0.68	0.46
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	36.84	13.55	4.70	2.30	0.87	0.77	0.33
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	33.10	14.18	3.22	3.01	1.07	0.64	0.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	29.71	12.06	2.37	3.23	1.94	0.65	0.22
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	38.48	13.82	3.24	2.24	1.12	0.50	0.50
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	35.00	13.72	3.26	1.72	1.03	0.69	0.86
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	24.03	9.93	5.77	2.56	1.28	0.32	0.32
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	101.29	5.04	0.56	4.48	0.00	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	89.16	14.28	4.76	2.60	1.30	1.73	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	68.74	18.51	7.93	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	94.53	13.40	7.05	2.82	1.41	2.47	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	85.73	12.35	3.63	5.09	1.45	0.00	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	56.30	11.71	6.12	1.40	1.57	0.87	0.35
Hepatocyte, donor1	11523-119I2	30.27	6.05	3.63	2.42	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	35.55	9.70	5.39	3.23	1.08	1.08	0.00
Hepatocyte, donor3	11684-122I1	41.72	11.04	2.45	2.45	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	64.62	2.61	18.28	1.31	4.57	1.31	0.65
Intestinal epithelial cells (polarized), donor1	11246-116E4	51.04	7.69	7.52	1.05	1.75	0.87	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	44.45	6.31	3.29	1.51	1.10	0.55	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	63.68	0.00	9.55	0.00	3.18	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	33.38	20.03	13.35	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	27.08	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	40.15	18.00	6.92	6.92	4.15	1.38	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	57.56	15.02	5.01	2.50	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	23.74	11.87	23.74	11.87	11.87	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	53.82	20.50	12.81	2.56	5.13	2.56	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	45.71	13.71	4.57	9.14	9.14	4.57	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	43.86	24.36	16.24	3.25	8.12	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	50.02	13.34	15.01	0.00	5.00	1.67	3.33
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	43.57	14.52	10.89	3.63	3.63	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	59.56	22.50	10.59	2.65	5.29	1.32	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	54.32	16.63	8.87	3.33	6.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	68.10	10.48	10.48	5.24	0.00	0.00	5.24
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	47.24	8.82	11.34	4.41	4.41	1.26	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	38.67	18.56	7.73	4.64	1.55	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	29.27	29.27	0.00	14.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	41.99	10.98	7.11	3.88	1.94	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	57.96	19.32	9.66	8.05	8.05	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	35.84	11.95	11.95	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	55.41	24.45	8.15	5.70	4.89	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	48.70	9.24	12.59	2.52	5.46	1.68	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	28.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	50.63	10.45	8.04	4.02	5.63	1.61	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	52.63	10.16	5.54	0.92	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	45.24	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	42.96	11.80	10.38	4.25	1.89	0.94	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	47.16	17.23	8.16	3.63	6.35	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	29.48	14.74	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	53.81	11.84	7.53	1.08	6.46	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	58.44	22.87	15.25	3.81	8.89	2.54	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	16.43	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	54.84	17.86	9.57	3.19	4.46	2.55	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	61.97	12.76	9.11	5.47	3.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	47.41	15.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	51.41	9.28	3.57	1.43	4.28	2.14	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	43.14	19.91	13.27	3.32	9.95	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	20.85	0.00	41.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	38.27	12.04	11.42	2.16	4.01	2.16	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	52.68	21.07	5.27	3.51	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	40.86	28.29	0.00	0.00	3.14	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	45.90	11.82	6.26	2.78	2.78	1.39	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	59.75	4.43	2.21	2.21	2.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	19.45	3.24	0.00	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	43.60	8.72	8.72	0.87	0.87	3.49	0.87
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	47.25	15.75	2.25	2.25	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	13.94	0.00	0.00	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	33.07	7.47	8.53	5.33	2.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	54.03	12.47	9.70	2.77	2.77	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	31.35	14.25	0.00	0.00	0.00	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	48.78	11.05	6.44	4.60	1.84	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	39.33	15.13	15.13	3.03	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	24.83	12.42	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	33.84	5.29	2.11	1.06	1.06	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	45.53	13.06	7.51	1.71	2.28	1.88	0.00
Keratinocyte - epidermal, donor2	11349-117G8	31.04	7.61	2.34	1.17	1.76	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	45.72	10.70	4.16	1.70	1.14	0.38	0.19
Keratinocyte - oral, donor1	11251-116E9	71.40	12.15	5.90	1.82	1.25	1.93	0.11
Keratocytes, donor1	11527-119I6	107.28	19.25	10.66	4.13	1.72	2.41	1.38
Keratocytes, donor2	11607-120I5	65.62	26.95	2.34	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	55.33	9.09	3.95	0.79	0.40	1.19	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	109.90	30.77	2.20	8.79	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	58.25	7.55	5.39	0.00	0.00	2.16	0.00
Lens Epithelial Cells, donor2	11609-120I7	67.12	6.80	4.38	1.38	1.04	1.50	0.58
Lens Epithelial Cells, donor3	11690-122I7	58.12	8.17	3.13	1.11	1.11	0.81	0.71
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	49.80	7.00	4.27	1.66	0.83	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	51.91	5.30	2.51	1.40	0.28	1.12	0.28
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	43.29	5.19	0.94	0.94	0.31	0.94	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	44.09	8.07	2.15	1.08	2.15	1.08	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	49.17	3.78	1.26	0.95	0.95	0.32	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	36.66	6.15	2.26	1.51	0.65	0.22	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	40.63	4.92	1.64	0.41	0.00	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	48.29	5.06	2.02	0.76	0.25	0.76	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	37.58	5.49	1.41	1.13	0.56	0.84	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	43.11	6.33	2.77	1.58	1.19	0.00	0.40
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	47.50	5.04	2.13	0.58	0.58	0.78	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	32.03	4.26	2.04	1.30	0.74	0.37	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	47.04	5.92	2.79	1.39	0.70	0.00	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	52.24	4.05	2.15	1.91	0.72	0.24	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	40.65	4.67	2.33	0.82	1.24	0.14	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	39.11	7.08	2.77	1.85	0.00	0.92	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	44.89	8.11	2.81	2.18	1.25	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	50.51	7.69	3.29	0.55	0.55	0.18	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	46.40	7.24	2.30	1.97	0.00	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	51.84	6.44	2.93	1.17	0.29	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	39.58	7.22	2.49	2.74	0.50	0.25	0.50
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	49.95	5.82	1.45	0.97	1.45	0.97	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	42.28	3.77	2.15	1.08	1.89	0.54	0.27
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	41.48	8.02	1.36	1.82	0.76	0.61	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	52.88	9.33	3.63	1.04	0.52	1.04	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	38.32	2.93	2.09	1.05	1.05	0.21	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	40.00	6.01	2.26	1.35	0.00	0.30	0.15
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	37.15	9.63	4.13	3.44	0.69	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	38.19	4.33	1.32	0.38	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	35.73	4.24	3.29	1.27	0.53	0.64	0.11
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	41.67	7.75	1.45	0.97	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	46.31	5.62	2.65	1.32	0.99	0.33	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	40.76	4.83	3.22	1.24	0.50	0.87	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	63.68	7.03	2.59	1.85	0.37	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	37.06	4.69	2.22	0.74	1.73	0.49	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	39.32	5.22	2.34	1.37	0.55	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	44.39	8.68	2.57	1.93	0.96	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	39.87	5.48	1.83	2.43	2.13	0.30	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	36.53	5.88	2.24	1.82	0.56	0.56	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	39.11	3.91	1.42	1.78	0.36	0.36	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	47.02	4.36	1.94	0.97	0.48	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	42.79	6.22	3.73	1.09	0.93	0.47	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	46.20	6.45	3.22	0.00	1.79	0.00	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	43.45	8.17	2.61	1.31	0.65	0.33	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	38.37	5.41	2.59	0.94	0.47	0.00	0.47
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	52.72	8.79	3.47	1.61	0.62	0.62	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	37.39	5.63	0.00	1.54	0.51	0.77	0.00
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	30.43	7.76	1.49	0.90	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	22.66	9.06	6.80	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	27.62	3.84	1.53	0.00	0.77	1.53	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	25.24	5.94	1.48	1.48	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	29.20	8.89	2.96	1.69	1.69	0.00	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	36.57	9.85	4.22	1.41	0.00	0.70	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	13.08	8.41	1.87	2.80	2.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	29.37	8.76	4.64	2.06	2.58	0.52	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	28.55	3.57	3.57	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	20.58	5.20	2.26	0.68	0.45	1.36	0.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	42.75	9.60	4.65	2.04	0.87	1.45	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	29.71	8.55	3.60	2.70	1.80	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	28.72	8.40	4.88	1.63	1.49	0.41	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	33.38	11.30	5.14	2.57	2.57	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	32.11	6.35	3.53	1.41	1.06	0.35	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	31.98	7.33	4.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	28.02	11.21	5.60	2.04	1.53	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	30.68	6.40	3.20	1.07	0.27	0.53	0.27
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	36.47	11.34	3.02	3.59	1.32	0.19	0.19
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	28.22	10.43	6.14	3.07	1.23	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	33.43	8.97	2.45	0.00	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	35.40	11.25	4.37	4.16	1.46	1.46	0.42
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	41.76	10.09	5.04	2.24	1.40	0.56	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	29.88	12.36	3.09	2.06	2.06	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	32.80	8.71	5.23	1.45	1.16	0.58	0.29
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	34.38	9.57	2.39	1.79	1.79	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	24.90	8.30	1.66	2.77	1.66	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	28.63	9.19	3.18	3.53	1.41	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	32.08	9.96	3.69	1.84	0.74	0.37	0.74
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	24.18	5.76	2.30	2.30	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	28.40	7.29	3.84	3.07	1.54	0.77	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	34.53	9.62	4.53	2.26	2.83	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	18.05	14.77	3.28	1.64	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	30.28	9.04	1.81	2.71	1.36	0.00	0.45
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	32.32	9.34	3.59	5.03	0.00	0.00	0.72
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	35.85	8.96	2.99	5.23	0.75	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	33.44	7.43	4.83	1.49	0.74	0.74	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	29.72	9.48	2.58	1.29	0.43	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	24.83	10.28	0.86	2.57	0.86	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	31.98	12.33	3.33	2.33	1.00	1.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	30.77	9.65	6.64	3.62	1.81	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	27.02	4.98	0.71	2.13	0.71	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	31.28	6.87	3.44	3.09	2.06	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	40.26	11.27	1.61	3.22	2.15	1.07	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	30.97	9.43	3.37	3.37	2.02	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	30.00	5.19	3.70	1.11	1.11	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	16.28	6.98	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	26.44	6.35	2.12	2.12	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	33.61	9.60	3.20	2.00	1.20	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	32.71	3.63	5.09	2.18	0.00	0.73	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	23.76	9.20	0.77	2.30	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	33.05	9.87	4.93	0.49	1.48	1.48	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	26.35	12.23	3.76	1.88	3.76	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	32.68	9.05	4.53	2.01	0.50	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	34.70	9.46	3.60	1.35	0.45	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	29.26	10.33	5.16	3.44	0.00	1.72	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	26.72	8.02	1.78	2.67	1.78	0.45	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	25.42	10.95	4.69	1.17	1.56	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	36.95	7.92	0.66	1.98	2.64	0.66	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	29.58	6.75	4.15	3.11	0.52	1.56	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	36.76	9.19	3.50	2.63	0.44	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	32.99	6.15	5.59	1.68	1.68	0.56	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	30.47	7.51	1.77	0.88	2.21	0.44	0.88
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	34.71	6.94	2.31	1.93	1.54	1.16	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	27.34	8.10	0.51	1.01	1.01	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	28.36	11.05	1.92	1.44	0.96	0.48	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	32.60	9.54	3.98	2.78	1.19	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	36.46	4.86	4.86	2.43	1.22	0.00	0.61
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	32.51	5.53	2.77	3.46	1.38	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	33.06	5.70	2.28	2.66	1.52	0.38	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	28.40	10.33	3.10	2.58	2.07	0.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	32.65	4.84	3.63	1.21	1.21	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	29.47	5.07	2.22	2.85	0.95	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	31.99	9.06	1.60	2.13	1.07	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	35.05	6.90	5.17	1.15	1.72	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	34.45	6.69	2.57	1.54	0.51	0.51	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	29.00	12.73	3.54	3.54	0.00	1.41	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	28.94	4.54	2.84	2.84	1.70	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	28.29	9.57	1.66	2.08	1.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	30.54	9.40	3.13	2.35	0.78	2.35	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	29.65	6.26	1.67	0.42	1.25	0.84	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	27.41	4.65	2.79	1.86	0.46	0.93	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	20.07	8.70	4.01	2.68	0.67	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	31.54	6.42	5.88	1.60	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.42	11.31	3.64	3.23	0.81	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	11.01	2.75	1.84	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	30.23	5.33	4.45	1.78	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	34.19	12.54	3.99	3.99	2.28	0.00	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	32.21	14.57	5.37	1.53	0.77	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	45.42	4.92	2.74	1.09	1.09	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	24.50	7.57	4.01	4.01	2.23	0.45	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	28.34	5.98	3.64	2.08	1.30	0.26	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	35.81	9.95	4.64	1.99	1.33	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	29.10	6.24	2.08	6.24	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	41.71	9.57	3.42	2.73	1.14	0.00	0.23
Macrophage - monocyte derived, donor2	11313-117C8	25.32	8.99	1.10	1.84	0.37	0.18	0.00
Macrophage - monocyte derived, donor3	11389-118C3	48.50	13.63	3.54	3.67	1.97	0.26	0.39
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	15.93	7.43	2.12	0.53	1.59	0.53	0.00
Mallassez-derived cells, donor2	11929-125I3	38.03	15.05	4.91	2.38	1.27	0.95	0.16
Mallassez-derived cells, donor3	11930-125I4	37.80	17.10	4.45	1.53	1.53	1.25	0.28
Mammary Epithelial Cell, donor1	11273-116H4	56.40	12.85	3.79	2.59	1.00	0.60	0.10
Mammary Epithelial Cell, donor2	11350-117G9	51.25	11.29	4.05	2.03	2.61	0.29	1.16
Mammary Epithelial Cell, donor3	11422-118F9	27.19	7.73	3.99	1.00	0.50	0.25	0.25
Mast cell - stimulated, donor1	11487-119E2	73.22	12.88	10.85	1.36	2.03	0.68	0.00
Mast cell, donor1	11563-120D6	62.72	12.54	3.03	3.03	0.32	0.32	0.00
Mast cell, donor2	11565-120D8	62.41	14.86	6.84	5.65	2.38	0.30	0.00
Mast cell, donor3	11566-120D9	72.94	13.96	7.88	5.85	1.80	1.58	0.23
Mast cell, donor4	11567-120E1	53.90	9.93	6.56	4.61	4.08	1.06	0.18
Mast cell, expanded and stimulated, donor5	11940-126A5	55.45	13.20	2.44	4.44	0.33	0.55	0.00
Mast cell, expanded and stimulated, donor8	11942-126A7	102.14	19.85	4.09	4.67	1.17	0.00	0.58
Mast cell, expanded, donor5	11939-126A4	39.46	10.90	1.95	2.75	0.57	0.11	0.00
Mast cell, expanded, donor8	11941-126A6	78.33	15.06	2.01	3.18	0.33	0.17	0.00
Melanocyte - dark, donor1	11502-119F8	56.42	4.88	2.09	0.70	0.60	0.10	0.00
Melanocyte - dark, donor2	11582-120F7	53.99	9.69	6.58	1.04	0.69	1.38	0.00
Melanocyte - dark, donor3	11663-122F7	49.84	11.30	7.75	2.54	3.26	1.74	0.65
Melanocyte - light, donor1	11274-116H5	31.50	7.76	6.35	2.12	0.94	0.24	0.00
Melanocyte - light, donor2	11351-117H1	32.76	6.82	6.14	0.68	1.36	0.00	0.00
Melanocyte - light, donor3	11423-118G1	25.15	1.73	1.73	1.73	0.00	0.00	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	57.16	8.95	7.91	1.98	2.08	1.25	0.31
Melanocyte, donor2 (MC+2)	12739-135I3	62.66	12.91	12.10	2.69	3.23	1.34	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	67.77	12.32	6.43	1.34	0.54	1.07	0.27
Meningeal Cells, donor1	11493-119E8	78.53	12.16	6.33	1.61	0.87	3.10	0.62
Meningeal Cells, donor2	11573-120E7	58.10	11.00	6.16	3.52	0.44	2.64	0.88
Meningeal Cells, donor3	11654-122E7	50.29	9.70	8.39	1.22	1.71	0.90	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	53.04	11.98	3.42	1.71	0.57	1.14	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	37.23	9.46	4.43	2.11	2.01	0.81	0.20
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	95.93	7.88	1.31	1.31	1.31	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	65.41	19.62	3.92	0.00	0.00	2.62	2.62
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	43.77	8.61	4.31	0.72	1.44	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	39.60	6.99	2.75	1.27	0.64	1.27	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	50.26	8.54	1.51	0.50	1.51	1.01	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	61.09	18.02	8.13	2.42	1.98	1.32	0.88
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	64.29	21.92	7.31	2.92	3.65	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	61.18	15.55	7.98	1.84	2.25	1.43	0.20
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	65.24	5.96	4.57	1.25	0.69	2.49	0.42
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	46.84	8.92	5.20	3.35	1.49	0.37	1.12
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	55.13	8.29	4.87	0.92	0.79	0.79	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	78.04	9.79	3.56	1.19	0.30	1.19	0.59
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	112.11	16.35	4.67	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	73.65	10.25	5.12	3.84	0.64	0.00	1.92
Mesenchymal stem cells - adipose, donor0	11217-116B2	51.75	15.60	6.03	2.84	0.35	1.06	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	50.66	7.51	5.94	1.56	0.31	0.63	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	40.64	16.69	2.18	0.00	1.45	1.45	0.00
Mesothelial Cells, donor1	11247-116E5	37.12	14.32	4.51	1.33	3.45	1.06	0.80
Mesothelial Cells, donor2	12156-128G5	39.04	13.01	6.01	3.00	0.50	2.00	0.50
Mesothelial Cells, donor3	11402-118D7	44.88	15.18	4.34	2.02	0.87	1.59	0.14
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	40.51	17.55	0.00	4.05	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	47.04	13.30	1.97	3.20	0.99	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	38.87	14.13	4.71	1.18	0.59	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	31.11	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	30.99	11.47	2.17	2.79	1.55	0.62	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	35.89	10.79	3.73	1.24	0.83	0.21	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	32.42	11.58	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	40.54	10.01	2.25	1.75	1.00	0.25	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	36.77	10.71	1.86	1.86	1.40	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	58.40	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	43.28	11.79	4.27	2.64	0.81	0.61	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	34.05	13.86	1.19	2.38	1.19	0.40	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	51.31	25.65	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	30.97	12.39	2.65	0.88	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	37.99	16.72	2.28	3.80	3.04	0.38	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	34.21	15.79	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	32.68	12.31	2.33	1.91	0.64	0.42	0.42
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	28.55	5.52	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	24.74	5.66	1.49	1.49	0.60	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	30.18	10.06	1.68	5.03	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	29.86	11.79	2.26	1.25	0.75	0.25	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	28.52	9.74	2.61	1.19	1.43	0.00	0.24
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	19.90	8.29	1.11	2.76	0.55	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	26.48	14.28	1.84	2.53	0.69	1.15	0.23
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	33.23	8.83	0.21	1.89	1.26	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	20.99	7.95	0.61	1.22	0.61	0.61	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	24.24	13.09	3.00	2.36	2.15	0.43	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	33.57	10.23	1.78	2.89	1.11	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	17.74	10.51	1.53	1.31	0.88	0.22	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	30.42	10.65	0.51	1.52	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	26.51	8.28	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	28.54	14.40	1.09	3.53	0.54	0.00	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	35.00	10.29	2.65	2.65	0.88	0.59	0.29
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	41.43	13.08	1.09	2.18	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	23.07	11.53	1.92	2.40	0.96	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	48.03	13.61	1.60	1.20	1.60	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	49.36	16.45	0.00	2.74	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	35.04	17.02	5.01	4.00	1.50	0.50	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	22.42	16.31	0.00	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	43.79	19.71	3.94	0.88	1.75	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	45.25	12.14	0.00	4.41	1.10	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	34.58	12.17	1.92	2.56	0.64	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	47.85	21.07	4.21	5.45	1.24	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	52.89	13.92	0.70	0.70	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	37.57	15.47	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	45.47	20.51	2.39	2.74	1.71	0.68	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	55.14	14.00	0.44	3.06	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	42.97	14.56	0.71	2.13	0.71	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	46.85	17.96	2.81	0.56	1.68	1.12	0.28
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	72.73	22.86	3.33	1.66	0.42	0.42	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	37.30	10.49	0.00	0.58	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	43.44	13.57	1.81	1.51	1.21	0.00	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	74.30	22.54	2.92	0.00	1.25	0.83	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	14.44	14.44	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	42.48	13.85	0.92	0.92	0.92	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	72.85	23.90	1.14	0.57	3.41	0.00	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	41.87	10.36	1.24	1.93	0.83	0.28	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	43.80	14.77	2.85	2.59	0.52	0.52	0.26
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	65.63	18.02	2.57	0.86	0.86	0.43	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	24.77	12.07	1.27	1.91	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	40.03	16.01	1.87	2.67	0.27	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	55.97	20.35	1.80	2.39	1.20	1.20	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	25.57	7.63	0.85	1.27	0.14	0.28	0.14
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	36.31	13.70	2.23	4.14	0.96	0.96	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	57.27	14.82	3.54	2.65	0.88	0.44	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	28.06	9.10	0.00	1.52	0.38	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	34.66	13.35	2.56	1.14	1.14	0.28	0.28
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	60.47	19.66	3.44	2.70	0.25	0.49	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	37.15	9.78	0.65	0.65	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	27.05	14.41	1.18	1.76	0.00	0.29	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	57.38	19.32	4.04	1.73	0.58	0.29	0.29
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	33.38	10.30	2.47	2.89	0.82	0.82	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	31.27	10.72	2.08	1.79	0.30	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	18.83	3.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	35.65	10.69	3.56	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	59.14	12.81	5.26	2.30	0.99	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	37.87	8.42	2.10	4.21	0.00	1.05	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	34.00	8.90	1.78	0.99	0.40	0.79	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	44.70	4.66	1.86	1.86	0.93	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	47.32	14.27	3.00	4.88	1.50	0.38	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	28.50	14.65	3.20	2.93	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	25.79	10.63	2.94	1.47	0.57	0.23	0.23
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	50.10	14.73	1.47	2.95	0.74	0.00	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	44.34	11.73	2.20	2.56	1.10	0.37	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	45.11	7.78	0.00	1.56	3.11	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	21.38	8.02	1.07	0.53	1.07	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	30.91	3.86	7.73	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	59.59	9.09	7.07	5.05	1.01	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	29.09	7.59	2.11	3.79	0.00	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	13.62	4.09	0.00	1.36	9.53	1.36	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	11.44	1.27	0.64	0.64	0.64	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	7.29	2.43	0.00	1.62	2.43	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	9.06	3.02	0.00	1.51	3.02	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	34.26	28.55	0.00	0.00	114.20	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	26.10	6.52	0.00	6.52	48.94	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	33.27	14.26	4.75	4.75	57.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	62.75	0.00	0.00	0.00	25.10	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	46.32	9.05	4.31	0.65	1.08	1.08	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	70.55	6.27	6.79	3.66	0.52	0.00	0.52
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	59.41	9.34	4.00	1.33	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	72.21	16.28	0.83	3.76	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	49.25	12.93	2.66	3.04	0.57	0.19	0.95
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	284.06	63.83	3.19	1.60	0.00	1.60	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	55.76	13.60	0.00	0.68	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	45.94	12.86	3.68	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	53.57	7.12	1.67	2.93	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	57.41	11.39	2.32	1.86	0.46	0.93	0.23
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	37.02	6.76	0.54	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	78.84	13.88	2.31	2.31	0.84	0.42	0.00
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	0.00	0.00	11.13	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	59.56	10.42	1.49	1.49	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	61.17	8.39	1.62	1.35	0.27	0.27	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	52.14	6.57	1.36	0.91	0.23	0.45	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	40.34	5.23	0.98	0.16	0.16	0.49	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	82.01	9.48	3.28	2.00	0.18	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	80.10	8.49	2.12	2.12	0.53	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	77.44	6.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	54.48	10.17	3.94	1.31	0.00	0.66	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	49.76	6.83	0.98	0.65	0.33	0.00	0.33
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	113.59	17.29	2.82	3.35	0.88	0.71	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	80.17	4.92	0.70	2.11	0.70	0.70	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	82.29	13.33	0.92	2.30	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	52.70	6.75	1.29	0.64	0.32	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	58.98	7.24	5.52	1.38	0.69	1.72	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	37.93	2.53	7.59	2.53	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	94.91	12.70	2.23	2.01	0.45	0.22	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	73.67	14.40	2.96	1.27	0.42	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	76.43	12.58	1.90	1.42	0.00	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	53.23	8.16	2.15	0.43	0.00	0.43	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	9.03	9.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	46.65	4.33	1.67	1.00	0.00	0.33	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	106.40	16.23	1.80	3.61	0.00	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	57.93	9.52	0.79	0.00	0.00	0.00	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	64.08	6.50	0.00	2.79	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	50.32	8.70	0.76	2.27	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	48.23	8.80	0.33	0.33	0.33	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	38.78	4.79	0.44	0.44	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	130.26	23.07	4.98	3.17	0.45	0.90	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	47.62	7.06	0.88	0.88	0.88	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	57.84	8.64	1.99	1.99	0.00	0.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	45.64	5.95	1.49	2.48	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	46.70	11.10	2.68	1.15	0.00	0.00	0.38
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	57.46	9.68	2.42	1.81	0.60	0.00	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	71.61	11.49	4.64	1.33	0.66	0.88	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	50.15	5.42	2.03	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	5.11	10.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	67.06	9.75	1.83	0.61	1.22	0.61	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	44.69	9.13	0.00	2.20	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	58.41	4.84	0.61	0.91	0.00	0.30	0.00
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	75.95	5.54	3.16	0.79	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	57.82	6.80	6.80	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	75.87	10.12	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	23.73	11.93	4.97	1.99	2.24	1.24	0.25
Myoblast, donor2	11322-117D8	39.12	12.08	5.95	2.49	1.53	1.73	0.38
Myoblast, donor3	11398-118D3	42.21	11.94	4.71	1.35	1.51	1.18	1.01
NK T cell leukemia cell line:KHYG-1	10777-110G3	82.16	7.00	1.75	1.46	0.88	0.00	0.00
Natural Killer Cells, donor1	11230-116C6	71.65	14.15	14.76	2.77	11.69	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	91.37	16.89	16.59	2.71	12.06	0.00	0.60
Natural Killer Cells, donor3	11387-118C1	74.36	10.86	14.54	0.92	12.70	0.55	0.00
Neural stem cells, donor1	11275-116H6	100.17	14.88	13.07	2.90	3.99	2.90	0.36
Neural stem cells, donor2	11352-117H2	23.11	3.85	19.26	1.93	3.85	7.70	0.00
Neurons, donor1	11494-119E9	81.93	31.86	10.24	1.14	2.28	2.28	0.00
Neurons, donor2	11574-120E8	66.27	9.91	5.50	1.54	0.66	0.88	0.44
Neurons, donor3	11655-122E8	117.57	19.73	10.69	2.47	0.82	2.47	0.00
Neutrophils, donor1	11233-116C9	50.11	4.64	12.99	0.93	7.42	0.00	0.00
Neutrophils, donor2	11314-117C9	46.38	2.90	0.00	0.00	2.90	0.00	0.00
Neutrophils, donor3	11390-118C4	58.03	19.55	11.61	0.61	1.22	0.61	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	92.73	8.79	6.17	1.90	0.36	1.90	1.54
Nucleus Pulposus Cell, donor2	11409-118E5	86.61	9.44	2.93	1.30	0.33	0.00	0.33
Nucleus Pulposus Cell, donor3	11462-119B4	87.84	6.42	3.41	1.20	0.40	0.60	0.00
Olfactory epithelial cells, donor1	11933-125I7	93.88	12.39	3.72	3.30	0.28	0.96	0.00
Olfactory epithelial cells, donor2	11934-125I8	89.89	16.36	6.22	2.32	0.87	1.45	0.14
Olfactory epithelial cells, donor3	11935-125I9	72.76	16.23	3.63	4.31	0.68	0.91	0.45
Olfactory epithelial cells, donor4	11936-126A1	74.02	12.27	4.09	2.43	0.49	0.88	0.29
Oligodendrocyte - precursors, donor1	11496-119F2	58.98	10.23	2.41	4.21	0.60	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	62.32	9.57	6.81	2.77	1.49	1.06	0.64
Osteoblast - differentiated, donor2	11353-117H3	38.87	11.43	3.43	2.29	1.14	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	25.45	3.72	1.24	1.24	0.00	0.62	0.62
Osteoblast, donor1	11277-116H8	49.64	11.92	7.23	1.95	2.15	1.95	0.39
Osteoblast, donor2	11354-117H4	61.10	14.75	4.92	3.51	0.70	1.40	1.40
Osteoblast, donor3	11426-118G4	51.36	10.13	3.55	3.55	1.07	0.71	0.36
Pancreatic stromal cells, donor1	11249-116E7	48.35	11.62	5.73	1.85	0.59	1.60	0.67
Pericytes, donor1	11491-119E6	87.46	6.01	4.56	2.11	0.78	2.11	0.56
Pericytes, donor2	11571-120E5	82.40	5.66	3.40	1.36	1.81	1.13	0.68
Pericytes, donor3	11652-122E5	77.11	12.21	7.12	1.63	1.42	0.81	0.20
Perineurial Cells, donor1	11499-119F5	55.49	8.59	3.28	2.15	0.34	0.57	0.45
Perineurial Cells, donor2	11579-120F4	54.29	8.00	5.06	1.29	0.83	1.56	0.18
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	89.88	11.16	6.37	2.23	1.27	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	81.29	11.02	7.84	1.71	3.92	0.24	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	59.79	11.26	4.66	1.16	2.59	0.26	0.13
Placental Epithelial Cells, donor1	11278-116H9	45.20	16.50	11.00	3.59	4.07	0.96	0.24
Placental Epithelial Cells, donor2	11355-117H5	48.79	8.87	1.11	0.00	2.22	0.00	0.00
Placental Epithelial Cells, donor3	11427-118G5	56.15	8.44	5.89	1.37	1.77	0.39	0.39
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	30.06	5.06	1.27	1.27	0.95	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	39.02	9.75	4.13	1.88	0.75	0.56	0.38
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	42.55	13.84	7.44	2.61	1.04	1.17	0.52
Preadipocyte - breast, donor2	11328-117E5	48.86	11.03	3.15	2.25	0.23	1.58	0.68
Preadipocyte - omental, donor1	11468-119C1	42.09	8.95	2.77	2.88	0.43	1.17	0.43
Preadipocyte - omental, donor2	11329-117E6	32.74	10.04	6.11	2.18	1.31	1.31	0.00
Preadipocyte - omental, donor3	11403-118D8	47.85	8.88	2.58	1.72	0.86	0.57	0.57
Preadipocyte - perirenal, donor1	11469-119C2	44.29	6.89	0.98	3.94	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	29.79	9.83	5.22	0.92	2.15	2.76	0.61
Preadipocyte - subcutaneous, donor2	11356-117H6	69.77	19.30	7.61	1.95	1.77	1.42	0.71
Preadipocyte - subcutaneous, donor3	11428-118G6	38.31	10.73	5.79	2.04	1.53	0.85	1.02
Preadipocyte - visceral, donor1	11280-116I2	58.03	15.28	5.87	2.42	1.68	1.96	0.56
Preadipocyte - visceral, donor2	11357-117H7	69.49	13.81	5.98	0.92	0.92	0.46	0.46
Preadipocyte - visceral, donor3	11429-118G7	60.71	12.75	4.91	2.72	1.25	1.46	0.10
Prostate Epithelial Cells (polarized), donor1	11253-116F2	46.92	7.54	11.01	1.06	6.34	2.41	0.15
Prostate Epithelial Cells, donor2	11331-117E8	36.43	9.61	4.60	1.62	1.90	1.08	0.14
Prostate Epithelial Cells, donor3	11404-118D9	34.84	5.76	2.02	1.29	0.73	0.37	0.31
Prostate Stromal Cells, donor1	11254-116F3	47.84	13.21	7.18	1.82	1.82	1.37	0.57
Prostate Stromal Cells, donor2	11332-117E9	59.17	11.65	9.14	3.05	2.15	1.97	0.54
Prostate Stromal Cells, donor3	11405-118E1	39.94	8.65	3.86	1.15	0.73	1.04	0.10
Renal Cortical Epithelial Cells, donor1	11516-119H4	79.20	14.23	4.01	1.82	1.46	1.46	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	48.45	9.63	4.02	0.90	0.62	0.76	0.28
Renal Epithelial Cells, donor1	11517-119H5	65.94	16.74	7.61	4.57	1.01	1.52	1.01
Renal Epithelial Cells, donor2	11597-120H4	64.73	9.25	6.40	0.71	1.42	0.00	0.71
Renal Epithelial Cells, donor3	11678-122H4	41.82	8.05	5.19	0.85	1.06	0.74	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	83.74	7.49	3.40	2.04	0.68	0.00	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	68.06	9.43	4.31	3.10	1.35	0.67	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	63.72	11.10	4.44	0.67	1.78	0.67	0.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	66.54	5.99	2.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	71.31	14.53	5.28	1.32	1.54	1.76	0.44
Renal Mesangial Cells, donor2	11598-120H5	73.36	15.05	3.76	2.51	1.25	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	71.29	6.94	6.10	1.39	1.11	1.11	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	64.69	16.64	6.71	1.88	0.54	1.07	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	64.52	16.45	3.80	0.84	0.84	2.11	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	71.55	11.76	7.52	1.54	0.19	1.54	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	50.82	8.82	6.22	2.33	0.00	1.30	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	105.17	11.37	5.68	1.14	0.00	1.99	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	77.18	17.50	10.29	1.03	1.03	0.00	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	83.30	10.04	8.53	1.76	1.76	2.01	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	58.13	8.42	1.47	2.00	0.40	0.80	0.13
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	67.90	4.47	4.47	0.89	2.68	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	51.73	8.81	12.66	0.55	1.65	0.55	0.55
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	52.78	11.60	7.54	1.74	2.32	0.00	1.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	45.12	7.02	7.15	1.82	1.82	1.04	0.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	54.02	8.54	5.86	2.28	0.99	0.70	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	39.60	8.92	9.48	0.67	1.78	0.89	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	58.05	10.17	9.18	1.61	1.74	1.36	0.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	52.56	8.86	6.88	1.52	0.93	0.93	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	66.57	12.02	5.78	2.54	1.62	1.16	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	48.33	7.39	4.24	1.23	0.82	0.68	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	58.09	8.02	7.41	0.76	0.61	0.76	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	39.06	6.09	3.58	0.72	1.43	0.18	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	47.91	8.18	4.88	0.57	0.43	1.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	50.65	6.65	4.83	1.61	1.50	1.50	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	51.11	8.85	5.53	1.77	1.11	0.66	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	51.04	8.03	4.21	0.38	1.72	1.72	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	45.46	9.04	4.84	1.02	0.65	0.37	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	46.79	7.52	8.46	1.88	1.50	0.75	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	46.05	8.63	3.58	1.33	0.80	1.19	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	49.74	8.27	6.04	1.27	0.97	0.49	0.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	43.35	8.21	5.35	0.95	1.72	1.15	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	43.68	6.41	4.16	1.07	1.07	0.96	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	49.61	5.89	6.73	1.40	1.40	0.56	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	51.27	9.23	5.30	2.22	0.17	1.54	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	47.59	4.56	4.19	0.91	1.82	0.55	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	50.40	8.22	6.38	1.10	0.74	1.35	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	44.06	8.33	7.12	1.34	1.48	1.07	0.54
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	52.36	8.26	8.26	0.94	1.65	0.47	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	46.03	10.52	5.16	0.79	1.79	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	48.17	11.93	9.12	1.64	1.40	1.87	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	41.89	8.50	6.64	1.24	1.66	0.83	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	54.86	7.08	10.40	1.33	1.99	1.55	0.44
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	47.83	8.77	4.80	1.46	1.67	1.46	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	47.91	9.29	6.46	1.88	1.48	0.81	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	50.92	10.73	4.94	1.53	1.70	0.51	0.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	49.93	8.10	6.56	0.96	1.35	0.58	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	54.85	12.04	5.16	1.38	1.55	0.86	0.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	52.40	10.97	4.12	1.51	1.23	0.69	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	54.50	9.85	7.55	1.97	1.15	0.82	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	45.16	7.33	2.90	0.34	1.36	1.02	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	51.34	9.03	5.47	0.44	1.63	1.04	0.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	49.31	6.40	5.60	1.07	0.27	0.53	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	42.31	4.01	4.01	0.28	0.41	1.11	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	47.86	7.38	3.33	0.71	1.43	0.71	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	57.84	8.87	6.25	1.61	0.40	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	46.52	3.96	4.43	1.60	0.85	0.47	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	55.20	6.64	5.24	1.05	0.70	0.70	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	49.26	6.04	3.32	1.51	1.51	0.60	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	53.12	6.36	4.65	1.47	0.73	1.22	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.47	7.86	6.99	0.73	2.62	1.60	0.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	57.80	6.69	6.08	0.61	1.22	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	50.33	7.84	3.32	2.41	0.60	0.60	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	49.31	6.11	5.20	0.90	2.71	1.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	48.23	5.99	8.69	0.90	3.00	1.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	48.88	5.31	7.67	0.59	1.77	0.59	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	42.26	5.76	9.39	0.85	1.07	1.07	0.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	38.46	10.22	6.01	0.00	1.20	0.00	0.00
Schwann Cells, donor1	11498-119F4	107.95	10.16	7.15	1.32	1.13	1.13	0.00
Schwann Cells, donor2	11578-120F3	20.41	10.21	0.00	0.00	3.40	0.00	6.80
Schwann Cells, donor3	11659-122F3	35.71	8.98	4.82	0.88	0.88	0.66	0.44
Sebocyte, donor1	11220-116B5	49.85	17.53	9.86	2.19	3.83	1.64	0.00
Sebocyte, donor2	11301-117B5	53.31	11.49	7.81	2.30	0.92	1.38	0.00
Sebocyte, donor3	11378-118B1	48.44	11.13	4.12	2.89	0.21	0.82	0.00
Sertoli Cells, donor1	11255-116F4	49.70	14.91	9.94	1.66	0.00	0.00	0.00
Sertoli Cells, donor2	11333-117F1	45.19	14.12	2.82	2.82	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	87.71	8.89	6.60	2.11	0.62	1.32	0.97
Skeletal Muscle Cells, donor2	11358-117H8	48.43	2.89	1.45	0.72	0.00	0.00	1.45
Skeletal Muscle Cells, donor3	11430-118G8	56.85	14.21	6.69	0.84	1.67	2.51	1.67
Skeletal Muscle Cells, donor4	11451-119A2	69.91	12.25	4.24	1.73	2.04	1.73	0.31
Skeletal Muscle Cells, donor5	11455-119A6	71.50	11.74	5.35	1.49	1.04	1.04	0.15
Skeletal Muscle Cells, donor6	11459-119B1	77.26	15.08	5.69	2.15	1.85	1.39	0.46
Skeletal Muscle Satellite Cells, donor1	11240-116D7	73.21	11.97	5.17	1.13	1.01	1.26	0.00
Skeletal Muscle Satellite Cells, donor2	11321-117D7	74.91	12.84	5.28	1.28	0.29	0.29	0.29
Skeletal Muscle Satellite Cells, donor3	11397-118D2	62.50	12.10	6.75	2.18	1.49	1.19	0.69
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	66.64	11.54	7.41	1.60	1.10	2.11	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	63.69	7.24	2.90	0.00	1.45	1.45	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	58.34	7.29	3.72	1.38	0.55	1.38	0.41
Skin - palm, donor1	10286-104F7	96.70	13.43	0.00	8.06	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	35.32	10.52	3.32	0.58	1.59	0.43	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	44.98	22.08	11.45	1.64	4.09	2.45	0.82
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	43.88	12.07	2.99	1.04	1.69	0.26	0.13
Small Airway Epithelial Cells, donor1	11256-116F5	48.93	9.45	5.42	0.83	1.25	0.70	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	66.25	9.56	2.53	2.95	1.27	0.28	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	54.98	12.48	10.57	2.11	2.96	2.11	0.63
Small Airway Epithelial Cells, donor3	11406-118E2	41.22	8.69	3.30	1.57	0.45	0.60	0.22
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	40.12	6.17	5.55	2.78	0.62	0.93	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	36.91	12.45	5.11	2.22	1.11	0.89	0.44
Smooth Muscle Cells - Aortic, donor0	11210-116A4	41.74	9.99	3.53	2.35	0.00	0.59	1.18
Smooth Muscle Cells - Aortic, donor1	11283-116I5	36.68	8.40	5.75	1.55	2.21	1.33	0.44
Smooth Muscle Cells - Aortic, donor2	11360-117I1	40.56	9.06	4.33	1.97	4.33	1.58	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	33.22	8.50	2.32	1.55	3.86	1.55	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	77.06	4.00	1.00	2.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	31.94	11.84	3.73	1.60	0.67	1.06	0.53
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	59.40	11.53	4.21	1.55	1.55	0.89	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	50.70	9.09	3.07	2.43	1.02	0.90	0.13
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	39.72	5.86	4.23	0.33	0.65	0.00	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	38.10	7.97	5.91	1.77	1.18	0.59	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	34.88	7.97	1.00	1.57	0.71	0.57	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	45.71	12.36	8.95	1.79	1.95	2.28	0.81
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	45.97	10.05	3.04	0.91	0.30	0.00	0.91
Smooth Muscle Cells - Carotid, donor1	11285-116I7	50.77	6.57	6.06	1.52	0.76	1.01	0.51
Smooth Muscle Cells - Carotid, donor2	11362-117I3	30.60	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	40.53	4.29	3.81	0.95	0.48	2.38	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	34.80	8.41	3.10	0.59	1.33	1.03	0.29
Smooth Muscle Cells - Colonic, donor2	11320-117D6	59.84	9.26	6.03	0.86	1.51	1.29	0.00
Smooth Muscle Cells - Colonic, donor3	11396-118D1	46.60	10.29	3.67	1.15	0.84	1.36	0.42
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	46.09	17.32	6.96	2.94	3.09	1.39	0.77
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	49.58	12.93	3.23	2.16	3.23	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	48.41	6.57	1.49	2.09	2.69	0.90	0.00
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	45.75	13.31	12.63	1.71	3.07	1.02	1.71
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	54.11	7.62	4.63	0.94	0.63	1.18	0.79
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	43.88	9.16	4.73	2.31	1.51	0.60	0.30
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	56.89	15.02	5.46	3.64	1.37	0.23	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	53.14	9.06	0.60	3.62	1.21	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	78.95	14.57	8.74	2.38	4.50	1.59	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	58.59	11.45	6.39	2.66	2.40	1.60	0.67
Smooth Muscle Cells - Prostate, donor2	11335-117F3	49.96	11.77	4.88	3.01	0.88	0.75	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	37.29	3.30	3.30	1.27	0.00	1.01	1.01
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	34.53	9.95	6.03	2.11	2.26	1.36	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	30.01	5.25	7.50	1.50	0.00	0.75	0.75
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	42.64	9.05	0.00	1.29	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	60.92	12.09	3.72	1.86	2.33	0.47	1.40
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	44.43	10.10	5.05	1.51	2.52	1.01	2.52
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	41.99	9.40	4.39	2.19	2.19	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	28.61	9.14	3.83	0.88	0.88	0.88	2.06
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	31.91	11.00	6.25	1.67	1.50	0.92	0.58
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	41.58	6.54	5.14	1.40	0.00	0.47	0.00
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	33.25	7.48	5.04	2.16	1.87	0.86	0.29
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	50.48	13.51	3.57	2.55	1.02	1.02	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	63.56	7.71	3.57	2.63	0.75	0.56	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	51.01	8.24	5.73	0.70	0.70	1.26	0.28
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	52.03	6.79	3.60	1.59	0.67	0.50	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	73.81	10.48	0.95	1.43	0.48	1.43	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	27.89	9.30	6.36	1.47	1.47	0.98	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	68.94	14.80	5.30	4.20	1.99	2.21	0.22
Smooth Muscle Cells - Uterine, donor3	11466-119B8	34.23	3.51	5.27	0.88	0.59	0.00	0.29
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	57.92	7.19	2.72	1.94	0.19	0.19	0.00
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	50.78	15.87	3.17	1.06	0.79	0.79	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	61.74	13.76	1.86	1.12	0.74	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	52.46	15.81	1.80	1.44	1.44	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	47.98	14.76	1.42	0.85	1.14	0.57	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	96.50	22.84	2.36	3.15	1.18	0.79	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	61.71	7.87	3.30	1.78	0.00	0.25	0.00
Smooth muscle cells - airway, control, donor2	11967-126D5	79.46	6.39	2.40	0.00	1.20	0.00	0.00
Smooth muscle cells - airway, control, donor3	11968-126D6	54.76	12.54	2.51	0.00	0.00	0.42	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	57.75	10.54	4.58	1.38	1.38	0.00	0.00
Synoviocyte, donor1	11291-117A4	48.48	10.77	6.73	1.85	2.36	0.67	0.00
Synoviocyte, donor2	11368-117I9	38.55	6.70	2.35	1.68	0.84	1.17	0.17
Synoviocyte, donor3	11440-118H9	55.63	7.37	3.80	1.34	0.00	0.45	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	66.46	17.51	11.43	4.29	2.14	2.86	1.43
Trabecular Meshwork Cells, donor2	11612-122A1	79.28	21.80	3.96	3.96	1.98	0.00	1.98
Trabecular Meshwork Cells, donor3	11693-123A1	66.45	10.42	4.86	3.01	2.08	1.62	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	37.35	8.32	4.09	1.94	0.86	1.08	0.29
Tracheal Epithelial Cells, donor2	11369-118A1	21.26	3.87	2.71	0.77	0.39	0.00	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	41.23	3.44	3.44	1.15	2.86	0.57	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	57.94	8.12	1.48	1.72	0.25	0.37	0.00
Urethra, donor2	10319-105A4	107.91	14.39	3.60	3.60	0.00	0.00	0.00
Urothelial Cells, donor1	11520-119H8	56.85	17.53	3.98	1.06	1.59	1.33	0.27
Urothelial Cells, donor2	11600-120H7	38.05	11.62	3.20	0.80	0.40	0.40	0.40
Urothelial Cells, donor3	11681-122H7	55.70	10.31	2.29	2.29	0.92	0.00	0.23
Urothelial cells, donor0	11216-116B1	73.56	12.93	2.23	1.34	1.56	0.22	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	83.64	15.13	6.23	2.67	2.67	0.89	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	61.47	2.86	8.58	5.72	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	60.24	8.90	0.00	2.05	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	48.21	5.85	3.79	0.34	0.34	0.34	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	45.90	8.13	1.16	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	81.22	2.08	6.25	4.16	0.00	1.04	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	78.93	6.42	2.75	1.84	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	70.29	13.69	2.74	2.74	0.91	0.00	0.00
Wilms' tumor cell line:G-401	10809-111A8	85.74	10.36	5.80	1.97	6.41	1.23	0.25
Wilms' tumor cell line:HFWT	10597-108E3	79.20	7.04	0.00	3.52	0.88	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	54.47	13.13	12.85	3.91	4.19	1.68	1.40
achilles tendon, donor2	10292-104G4	68.20	10.33	8.27	2.07	2.07	0.00	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	77.25	12.49	7.65	1.53	1.78	2.04	1.27
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	61.99	10.45	9.75	2.09	44.58	0.23	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	98.77	9.73	11.75	0.83	2.61	0.83	0.36
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	92.25	16.05	9.80	2.18	4.08	2.99	0.27
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	57.90	8.43	7.59	2.25	3.94	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	75.50	9.31	5.50	1.27	1.06	0.42	0.42
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	99.63	11.43	4.36	2.45	2.45	0.54	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	43.62	5.29	5.29	0.88	2.20	0.88	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	119.24	15.93	9.80	3.27	5.31	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	116.10	8.54	3.88	2.33	1.94	0.39	0.39
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	65.87	9.75	9.94	0.92	2.21	1.29	0.92
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	46.81	7.80	11.70	0.00	0.00	3.90	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	109.92	15.57	8.60	1.86	3.72	0.93	0.00
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	110.03	23.30	20.19	3.37	4.40	0.78	0.52
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	75.40	13.15	9.94	2.34	1.46	1.46	0.29
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	54.84	6.97	3.25	2.32	1.86	0.00	0.93
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	91.30	13.16	13.98	4.11	5.35	0.41	0.82
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	71.21	27.63	2.76	4.91	0.31	0.31	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	79.37	19.20	3.84	5.97	4.69	1.28	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	62.48	18.50	10.31	6.07	2.43	0.91	0.30
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	63.31	19.98	7.22	4.09	3.61	0.72	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	64.82	11.14	7.57	0.45	2.00	0.22	0.45
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	81.39	16.68	8.67	3.67	3.00	0.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	87.34	11.15	7.43	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	65.16	12.43	3.77	3.39	2.26	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	120.37	10.47	3.93	2.18	0.87	0.44	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	76.85	13.12	0.00	5.62	1.87	0.00	0.00
adenocarcinoma cell line:IM95m	10796-110I4	34.85	10.13	0.24	2.35	0.24	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	48.09	6.36	2.02	2.17	0.47	0.47	0.00
adipose, donor1	10184-103D4	134.29	8.21	5.86	0.59	1.76	1.76	0.59
adipose, donor2	10185-103D5	97.73	6.08	1.62	1.22	0.81	1.22	0.00
adipose, donor3	10186-103D6	88.49	3.81	3.00	1.09	0.54	1.09	0.00
adipose, donor4	10187-103D7	90.14	1.73	7.80	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	87.12	21.62	2.68	3.95	1.42	0.79	0.63
adrenal gland, adult, pool1	10081-102A9	58.20	3.64	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	97.25	18.28	2.93	1.07	1.33	1.20	0.00
alveolar cell carcinoma cell line:SW 1573	10708-109H6	129.70	27.15	6.79	3.93	2.50	1.07	0.36
amniotic membrane cells, donor1	12235-129G3	25.50	10.90	1.62	3.71	0.70	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	37.19	7.10	3.38	2.37	1.35	2.37	0.00
amniotic membrane cells, donor3	12237-129G5	38.59	10.90	2.06	2.95	0.59	0.00	0.29
amygdala - adult, donor10196	10167-103B5	61.66	28.46	8.30	1.19	0.00	2.37	3.56
amygdala, adult, donor10252	10151-102I7	119.02	19.67	3.45	4.66	0.81	1.01	0.20
amygdala, newborn, donor10223	10360-105E9	80.69	18.72	6.13	5.49	9.68	0.97	1.61
anaplastic carcinoma cell line:8305C	10428-106D5	66.98	6.62	2.42	1.02	0.64	0.13	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	79.20	14.34	4.85	1.76	2.43	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	82.84	6.01	2.67	0.67	3.67	0.33	0.33
aorta, adult, pool1	10052-101G7	75.12	10.00	2.55	1.96	0.00	0.78	0.20
appendix, adult	10189-103D9	80.73	8.93	3.49	1.55	0.39	1.55	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	125.54	14.45	4.82	1.03	1.03	1.38	0.69
artery, adult	10190-103E1	55.71	5.43	0.00	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	45.20	6.66	2.32	0.87	0.58	0.29	0.00
b cell line:RPMI1788	10427-106D4	89.07	11.90	7.29	2.08	3.27	0.74	0.30
basal cell carcinoma cell line:TE 354.T	10702-109G9	32.74	7.77	4.44	0.83	0.28	0.28	0.28
bile duct carcinoma cell line:HuCCT1	10432-106D9	52.20	14.29	3.57	3.27	1.89	1.09	0.20
bile duct carcinoma cell line:TFK-1	10496-107C1	46.70	10.21	2.18	0.84	0.67	0.84	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	153.79	15.66	6.15	5.03	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	58.99	8.69	4.56	2.39	0.11	0.87	0.22
blood, adult, pool1	10053-101G8	42.08	0.00	2.21	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	53.95	18.84	0.86	3.43	0.00	0.00	0.00
bone marrow, adult	10192-103E3	49.26	6.75	4.72	2.70	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	60.48	15.38	1.03	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	63.14	18.82	7.80	3.79	1.78	1.22	1.11
brain, fetal, pool1	10085-102B4	154.94	21.37	2.67	5.34	2.67	5.34	0.00
breast carcinoma cell line:MCF7	10482-107A5	77.64	14.54	1.65	4.96	0.99	0.00	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	75.77	19.72	3.99	2.50	0.62	0.87	0.12
breast, adult, donor1	10080-102A8	50.51	6.31	1.26	0.63	0.63	0.63	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	53.48	12.83	4.70	3.43	0.64	1.40	0.13
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	72.67	13.91	1.86	1.55	0.62	0.00	0.31
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	63.08	16.58	4.37	3.22	4.37	0.92	0.92
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	39.22	9.20	1.45	2.18	0.73	0.48	0.00
carcinoid cell line:NCI-H1770	10703-109H1	136.35	12.22	3.76	1.41	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	51.30	7.11	5.14	2.73	0.77	0.77	0.22
carcinoid cell line:SK-PN-DW	10719-109I8	71.62	8.87	1.58	1.27	0.95	1.58	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	150.92	11.98	5.32	1.33	0.53	0.80	0.00
caudate nucleus - adult, donor10196	10177-103C6	54.11	14.97	4.61	4.61	1.15	2.30	0.00
caudate nucleus, adult, donor10252	10164-103B2	103.91	20.75	7.36	5.35	1.00	2.68	1.17
caudate nucleus, adult, donor10258	10379-105H1	106.22	32.09	6.88	3.06	0.00	3.06	2.29
caudate nucleus, newborn, donor10223	10354-105E3	102.18	23.81	6.59	6.23	8.06	1.83	1.10
cerebellum - adult, donor10196	10173-103C2	128.18	67.01	20.39	20.39	2.91	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	182.12	41.85	19.86	12.17	3.42	4.27	0.85
cerebellum, adult, pool1	10083-102B2	108.66	20.35	10.00	4.83	1.38	1.03	0.00
cerebellum, newborn, donor10223	10357-105E6	127.03	37.36	4.15	5.81	3.32	0.00	0.00
cerebral meninges, adult	10188-103D8	82.70	17.15	5.55	3.03	0.50	1.26	0.50
cerebrospinal fluid, donor2	10294-104G6	55.55	9.50	0.73	0.73	0.73	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	50.90	8.48	2.44	2.73	0.72	0.14	0.00
cervical cancer cell line:ME-180	10553-107I4	102.08	19.55	6.13	3.48	2.32	0.83	0.00
cervix, adult, pool1	10013-101C4	82.94	11.02	5.67	1.89	0.52	0.73	0.21
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	63.54	11.98	4.74	4.04	2.79	1.81	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	108.42	11.76	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	76.18	8.33	2.98	1.74	0.87	0.37	0.25
choriocarcinoma cell line:SCH	10785-110H2	45.96	6.28	0.37	0.37	0.37	0.00	0.00
choriocarcinoma cell line:T3M-3	10618-108G6	50.28	10.20	0.24	2.13	0.24	0.24	0.47
chorionic membrane cells, donor1	12238-129G6	22.22	4.84	2.56	0.85	1.14	0.28	0.00
chorionic membrane cells, donor2	12239-129G7	44.15	8.55	4.57	1.29	0.80	1.09	0.30
chorionic membrane cells, donor3	12240-129G8	41.76	3.85	3.85	2.20	0.00	0.00	0.00
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	49.48	6.06	3.03	0.00	3.03	1.01	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	75.69	10.95	6.72	2.31	2.11	1.15	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	80.04	9.71	6.12	2.53	2.11	0.84	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	57.52	18.23	8.99	1.28	3.85	1.54	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	67.73	17.90	7.50	1.45	1.94	0.73	0.24
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	68.82	20.56	8.14	1.83	3.66	0.81	0.00
chronic myelogenous leukemia cell line:K562	10454-106G4	64.78	21.20	10.60	2.94	5.30	1.77	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	153.51	18.77	13.03	3.91	3.39	2.09	0.52
clear cell carcinoma cell line:JHOC-5	10638-108I8	62.17	13.26	2.97	1.60	0.69	0.23	0.46
clear cell carcinoma cell line:TEN	10636-108I6	65.59	13.19	6.25	1.91	4.51	1.74	0.17
colon carcinoma cell line:CACO-2	10513-107D9	58.94	5.86	10.98	0.55	6.04	2.93	0.37
colon carcinoma cell line:COLO-320	10420-106C6	87.04	7.22	7.60	1.14	0.76	2.28	1.52
colon, adult, donor1	10082-102B1	76.16	13.09	4.76	4.76	0.00	1.19	0.00
colon, adult, pool1	10014-101C5	64.04	11.05	3.29	1.76	1.18	0.82	0.00
colon, fetal, donor1	10070-101I7	77.25	6.80	0.00	1.24	0.62	0.00	0.00
common myeloid progenitor CMP, donor1	12130-128D6	142.09	36.67	13.75	4.58	27.50	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	75.11	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	84.14	18.27	5.95	1.70	10.20	2.12	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	71.99	13.28	3.77	3.32	3.17	0.45	0.30
cord blood derived cell line:COBL-a untreated	10449-106F8	70.51	15.09	3.81	2.12	1.97	0.42	0.14
corpus callosum, adult, pool1	10042-101F6	62.47	16.14	5.86	5.09	1.88	1.22	0.33
cruciate ligament, donor2	10295-104G7	64.84	9.73	2.43	1.62	0.81	0.81	0.00
diaphragm, fetal, donor1	10069-101I6	41.73	4.82	1.61	3.21	0.00	0.80	0.00
diencephalon, adult	10193-103E4	52.32	12.00	3.12	4.80	0.96	1.20	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	49.83	9.87	13.09	2.53	0.92	0.23	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	24.11	10.51	2.56	3.33	0.00	0.26	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	67.16	17.33	5.78	1.93	3.61	0.96	0.24
ductus deferens, adult	10196-103E7	74.25	14.95	4.49	1.99	0.50	1.50	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	70.57	7.20	7.20	4.32	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	52.23	8.83	5.15	2.94	0.00	0.74	0.00
dura mater, adult, donor1	10041-101F5	56.41	12.31	6.03	2.81	1.07	1.40	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	145.68	21.32	42.42	1.78	19.10	6.00	1.78
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	102.17	19.49	21.64	3.01	4.87	3.15	1.43
embryonic pancreas cell line:1B2C6	10604-108F1	67.21	20.35	0.00	3.08	1.23	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	36.02	16.35	1.21	3.33	0.30	0.00	0.30
embryonic pancreas cell line:1C3IKEI	10606-108F3	70.39	20.07	2.78	3.70	0.31	0.31	0.62
embryonic pancreas cell line:2C6	10603-108E9	70.93	42.03	1.31	10.51	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	50.61	11.73	2.35	0.67	1.34	0.00	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	107.29	22.84	5.62	4.35	1.45	0.72	0.36
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	64.00	13.67	5.47	1.61	2.73	0.48	0.16
epidermoid carcinoma cell line:A431	10426-106D3	40.24	9.12	4.11	1.56	1.67	0.44	0.22
epidermoid carcinoma cell line:Ca Ski	10431-106D8	62.14	16.28	4.73	1.65	2.20	1.54	0.11
epididymis, adult	10197-103E8	60.91	12.77	6.28	2.72	0.00	0.84	0.21
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	58.90	9.93	5.32	1.77	1.24	1.06	0.18
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	52.30	14.94	4.72	1.18	3.54	0.79	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	48.23	20.57	1.57	4.06	0.39	0.39	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	57.08	19.59	1.48	3.35	0.39	0.10	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	47.05	21.29	1.79	3.81	0.67	0.22	0.11
esophagus, adult, pool1	10015-101C6	57.55	9.87	2.97	2.55	0.32	0.53	0.11
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	85.54	10.65	11.52	2.13	5.89	2.25	1.00
eye - muscle inferior rectus, donor1	10272-104E2	94.17	21.73	0.00	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	44.19	12.63	2.10	4.21	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	53.58	13.39	1.49	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	75.67	4.59	1.15	3.44	0.00	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	72.87	8.74	0.00	0.00	4.37	0.00	0.00
eye, fetal, donor1	10054-101G9	94.58	12.20	3.05	1.78	0.51	2.29	0.51
fibrosarcoma cell line:HT-1080	10758-110E2	64.88	11.54	3.46	1.67	1.03	0.26	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	72.65	18.04	2.85	4.51	1.66	0.71	0.24
frontal lobe, adult, pool1	10040-101F4	82.38	17.73	7.51	4.41	1.69	3.47	0.84
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	80.77	11.41	4.20	2.70	2.70	1.80	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	30.36	8.96	5.30	1.74	1.83	0.46	0.37
gall bladder, adult	10198-103E9	45.39	11.11	5.79	2.90	0.72	1.21	0.00
gamma delta positive T cells, donor1	11937-126A2	74.62	13.42	4.83	2.68	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	58.64	8.59	4.86	0.75	0.37	0.00	0.00
gastric adenocarcinoma cell line:MKN1	10614-108G2	32.32	9.29	3.80	2.32	0.84	0.84	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	86.84	25.53	8.32	5.61	1.93	1.93	0.19
gastric cancer cell line:AZ521	10549-107H9	58.37	10.49	3.44	1.48	1.48	1.31	0.98
gastric cancer cell line:GSS	10560-108A2	32.95	15.56	6.41	3.66	0.92	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	52.55	3.66	4.57	1.14	2.51	1.37	0.23
giant cell carcinoma cell line:LU65	10487-107B1	87.89	20.54	2.64	2.41	1.38	0.46	0.34
giant cell carcinoma cell line:Lu99B	10433-106E1	75.02	12.88	8.54	2.10	1.26	1.40	0.56
glassy cell carcinoma cell line:HOKUG	10688-109F4	37.91	12.47	2.24	1.50	0.50	0.50	0.00
glioblastoma cell line:A172, tech_rep1	10444-106F3	46.87	18.89	14.36	6.02	4.64	2.22	0.95
glioblastoma cell line:A172, tech_rep2	10444-106F3	55.05	23.03	14.61	7.58	3.37	1.40	0.84
glioblastoma cell line:T98G	10485-107A8	72.40	10.38	6.18	2.21	1.99	0.88	0.11
glioma cell line:GI-1	10413-106B8	80.25	11.42	4.39	3.51	1.17	0.88	0.29
globus pallidus - adult, donor10196	10175-103C4	59.04	21.14	2.92	0.73	2.92	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	97.15	16.11	7.32	4.88	1.22	0.98	0.24
globus pallidus, adult, donor10258	10367-105F7	101.32	20.54	2.74	2.74	1.37	1.37	0.00
globus pallidus, newborn, donor10223	10364-105F4	64.48	18.12	3.20	4.80	9.06	0.00	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	100.33	26.92	17.13	2.45	31.81	0.00	2.45
granulocyte macrophage progenitor, donor2	12135-128E2	54.64	0.00	0.00	0.00	10.93	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	52.27	5.23	5.23	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	69.44	8.32	2.24	2.56	0.96	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	61.52	3.67	3.67	0.46	3.21	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	42.53	4.57	3.20	1.37	1.83	0.00	0.46
hIPS +CCl2, biol_rep3	14385-156C2	45.73	8.37	2.58	0.00	2.58	0.64	0.00
hIPS, biol_rep1	14380-156B6	31.62	10.06	7.19	1.44	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	34.98	3.43	5.49	0.00	3.43	2.06	0.69
hIPS, biol_rep3	14382-156B8	70.62	25.38	3.31	6.62	4.41	1.10	1.10
hairy cell leukemia cell line:Mo	10712-109I1	74.71	12.36	5.46	2.59	11.49	0.57	0.00
heart - mitral valve, adult	10205-103F7	55.91	8.07	4.19	0.90	1.20	0.90	0.60
heart - pulmonic valve, adult	10206-103F8	61.97	6.01	1.31	2.88	0.26	0.00	0.26
heart - tricuspid valve, adult	10207-103F9	40.80	9.16	0.00	5.83	0.83	0.00	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	49.38	8.77	1.63	2.65	0.41	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	56.21	14.90	3.41	3.83	0.00	1.28	0.43
heart, adult, pool1	10016-101C7	33.12	6.67	2.76	2.76	0.46	0.46	0.46
heart, fetal, pool1	10046-101G1	72.39	8.01	5.13	2.16	0.21	0.72	0.41
hepatic mesenchymal tumor cell line:LI90	10778-110G4	42.27	8.64	1.23	2.16	0.31	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	127.24	5.95	0.00	2.38	1.19	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	94.69	6.96	6.63	2.10	2.98	0.88	0.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	88.97	7.16	9.10	1.94	1.82	1.09	0.12
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	95.70	7.17	7.98	1.31	1.62	1.52	0.40
hepatoma cell line:Li-7	10484-107A7	73.85	11.01	6.01	2.00	1.33	1.45	0.22
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	57.69	8.04	6.83	2.21	3.52	1.01	0.70
hippocampus - adult, donor10196	10169-103B7	78.55	29.34	3.79	3.79	0.95	0.00	0.95
hippocampus, adult, donor10252	10153-102I9	117.36	17.76	5.10	6.74	0.82	2.04	0.61
hippocampus, adult, donor10258	10374-105G5	84.15	30.37	4.98	5.98	1.00	1.99	3.49
hippocampus, newborn, donor10223	10363-105F3	71.20	20.09	3.88	5.29	6.34	1.41	0.35
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	97.66	4.88	7.32	0.00	3.05	0.61	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	77.95	2.16	3.73	0.39	2.55	0.79	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	78.96	2.79	5.08	0.00	0.76	0.51	1.02
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	87.96	3.38	3.95	0.56	1.69	1.13	0.56
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	99.67	4.13	2.84	0.52	0.77	1.81	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	82.38	4.93	2.28	0.00	0.76	0.38	0.38
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	112.69	6.71	4.38	0.29	2.63	1.17	0.88
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	94.36	6.03	4.95	0.86	1.72	1.08	0.86
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	99.26	8.76	6.26	1.25	3.34	1.67	1.67
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	47.83	6.63	4.26	1.18	1.42	1.66	0.71
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	92.73	7.71	6.91	0.96	1.29	0.80	0.48
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	60.60	6.06	3.37	0.00	2.69	0.67	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	64.47	2.66	3.44	0.16	2.19	0.31	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	62.89	4.42	3.93	0.98	1.47	0.49	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	88.15	2.62	5.24	0.00	0.87	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	94.31	6.30	3.63	0.19	0.38	1.15	0.38
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	84.60	2.62	3.05	0.44	0.87	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	128.44	8.00	2.00	0.50	0.50	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	111.90	3.96	6.22	0.57	1.88	0.75	0.57
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	108.68	6.37	5.91	0.45	0.45	0.91	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	117.15	7.20	7.52	0.94	1.57	0.00	0.31
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	80.34	6.37	3.76	0.82	0.98	0.65	0.82
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	75.19	7.26	4.06	0.87	0.87	0.87	0.29
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	113.29	8.37	4.78	0.90	0.30	1.20	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	102.35	3.33	5.36	0.92	3.14	0.74	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	95.00	2.28	2.85	0.00	2.57	1.14	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	123.72	3.67	8.57	2.04	4.90	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	119.00	6.34	4.93	0.35	0.35	2.11	1.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	111.49	4.12	2.53	0.00	1.58	0.00	1.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	105.92	6.66	2.12	0.61	0.30	0.30	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	108.60	12.41	3.10	1.03	2.07	2.59	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	140.14	11.29	0.66	0.00	0.66	0.00	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	118.00	10.26	6.41	1.03	2.31	1.03	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	86.92	9.20	6.65	0.26	2.81	0.51	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	140.84	12.12	6.06	2.27	1.51	2.27	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	138.46	11.43	7.39	0.67	3.02	1.01	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	86.94	2.17	5.55	0.48	1.69	1.45	0.48
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	91.36	4.46	4.01	0.00	2.23	1.34	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	118.54	4.39	3.90	1.95	2.44	1.95	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	97.80	4.58	3.67	0.31	0.31	0.92	0.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	279.78	13.01	9.76	0.00	3.25	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	132.38	12.24	3.64	0.66	0.99	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	125.33	4.93	2.74	1.64	1.64	1.64	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	118.34	7.24	3.62	1.45	1.45	0.36	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	92.17	5.34	3.20	0.71	0.71	1.07	0.71
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	107.40	13.13	3.58	0.00	2.39	1.19	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	87.35	7.72	6.77	1.08	1.22	0.95	0.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	122.31	10.24	3.23	1.62	1.08	1.62	0.54
immature langerhans cells, donor1	11904-125F5	58.12	11.62	8.48	2.42	9.93	0.48	0.24
immature langerhans cells, donor2	11905-125F6	48.32	7.13	6.34	3.96	3.96	0.79	0.00
insula, adult, pool1	10039-101F3	96.62	26.97	10.69	5.39	2.27	3.60	2.46
keratoacanthoma cell line:HKA-1	10791-110H8	55.28	8.78	1.95	1.95	0.33	0.33	0.00
kidney, adult, pool1	10017-101C8	58.98	12.72	4.71	3.60	1.20	0.80	0.40
kidney, fetal, pool1	10045-101F9	92.66	10.40	6.65	2.33	1.27	1.70	0.28
large cell lung carcinoma cell line:IA-LM	10509-107D5	85.07	8.95	3.55	1.70	1.28	0.85	0.28
large cell lung carcinoma cell line:NCI-H460	10839-111E2	49.35	5.39	2.35	0.69	0.41	0.41	0.28
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	93.22	18.72	1.83	4.22	1.10	0.37	0.00
left atrium, adult, donor1	10079-102A7	49.04	5.45	1.09	1.63	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	56.63	3.54	0.00	1.52	0.00	0.51	0.00
leiomyoblastoma cell line:G-402	10721-110A1	103.97	18.33	3.56	3.56	2.46	0.82	0.27
leiomyoma cell line:10964C	10569-108B2	39.52	11.86	6.11	1.08	1.44	1.44	0.72
leiomyoma cell line:15242A	10570-108B3	38.59	12.50	2.17	2.72	3.26	0.00	0.54
leiomyoma cell line:15425	10571-108B4	41.76	15.54	6.31	1.94	1.70	1.21	0.97
leiomyosarcoma cell line:Hs 5.T	10722-110A2	31.75	6.35	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	80.51	26.14	7.32	1.05	1.05	1.05	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	147.69	18.06	6.85	2.24	4.13	1.18	0.12
liposarcoma cell line:KMLS-1	10782-110G8	45.77	9.53	2.97	1.56	0.16	1.41	0.16
liposarcoma cell line:SW 872	10726-110A6	72.98	15.72	5.48	3.78	1.46	0.85	0.24
liver, adult, pool1	10018-101C9	44.24	9.56	2.27	2.27	0.65	0.16	0.00
liver, fetal, pool1	10086-102B5	35.75	11.29	0.00	0.94	0.00	0.94	0.94
locus coeruleus - adult, donor10196	10182-103D2	86.77	21.44	4.52	4.67	2.04	0.29	0.44
locus coeruleus, adult, donor10252	10165-103B3	71.05	15.50	5.35	3.69	1.85	0.74	0.00
locus coeruleus, adult, donor10258	10375-105G6	52.48	10.44	5.08	3.10	0.85	1.13	0.28
locus coeruleus, newborn, donor10223	10362-105F2	81.60	21.03	7.57	3.79	7.99	1.68	1.68
lung adenocarcinoma cell line:A549	10499-107C4	36.40	8.72	3.18	2.08	0.42	0.42	0.42
lung adenocarcinoma cell line:PC-14	10408-106B3	48.26	10.34	2.76	0.69	0.00	1.38	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	44.82	7.65	3.03	0.79	1.19	0.26	0.00
lung, adult, pool1	10019-101D1	41.23	7.32	1.77	0.95	0.24	0.35	0.00
lung, fetal, donor1	10068-101I5	69.92	12.84	6.85	4.00	0.57	2.28	0.29
lung, right lower lobe, adult, donor1	10075-102A3	59.11	9.16	0.92	4.12	0.00	0.46	0.00
lymph node, adult, donor1	10077-102A5	77.16	13.25	0.95	2.37	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	91.40	12.49	1.97	1.97	1.32	0.22	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	48.15	5.13	6.94	1.96	0.75	1.06	0.45
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	36.53	6.80	2.55	1.70	0.00	0.00	0.00
mature adipocyte, donor1	12231-129F8	20.87	7.10	0.89	1.33	0.44	0.00	0.00
mature adipocyte, donor2	12232-129F9	33.41	7.68	1.87	2.08	1.25	0.42	0.21
mature adipocyte, donor3	12233-129G1	35.80	7.82	2.84	0.47	0.47	0.71	0.00
mature adipocyte, donor4	12234-129G2	44.48	6.05	1.58	1.32	0.26	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	42.65	12.87	3.10	2.14	0.71	0.24	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	94.75	28.20	5.64	9.02	1.13	2.26	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	137.19	26.48	6.80	6.07	1.47	1.47	0.55
medial frontal gyrus, adult, donor10258	10368-105F8	135.65	35.26	3.18	6.67	1.27	2.22	0.95
medial frontal gyrus, newborn, donor10223	10352-105E1	104.49	27.30	9.38	5.54	10.24	2.56	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	180.90	42.36	10.13	9.45	1.69	2.53	1.35
medial temporal gyrus, adult, donor10252	10156-103A3	128.40	27.80	7.64	5.09	0.85	0.85	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	80.90	63.57	11.56	3.85	0.00	1.93	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	129.18	14.35	14.35	14.35	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	92.25	22.61	4.31	3.23	10.05	0.36	0.72
medulla oblongata - adult, donor10196	10174-103C3	43.48	12.33	3.89	2.60	0.00	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	75.08	20.12	4.49	3.87	0.77	1.55	0.62
medulla oblongata, adult, pool1	10038-101F2	59.51	14.04	6.61	4.08	0.98	1.96	0.33
medulla oblongata, newborn, donor10223	10361-105F1	67.70	23.61	11.11	5.90	2.78	0.69	0.35
medulloblastoma cell line:D283 Med	10838-111E1	115.13	11.96	5.76	1.11	1.11	1.55	0.22
medulloblastoma cell line:ONS-76	10759-110E3	30.69	7.21	2.93	1.96	0.98	0.12	0.61
melanoma cell line:COLO 679	10514-107E1	40.54	11.07	11.36	1.44	3.74	2.30	0.29
melanoma cell line:G-361	10465-106H6	48.05	12.22	2.44	1.90	0.00	0.54	0.00
meningioma cell line:HKBMM	10691-109F7	60.24	11.58	1.81	1.45	0.18	0.18	0.18
merkel cell carcinoma cell line:MKL-1	10843-111E6	138.34	27.32	7.93	1.76	1.76	2.64	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	113.28	15.55	9.07	1.30	1.04	2.33	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	63.21	13.50	6.90	2.45	1.38	2.30	1.07
mesenchymal precursor cell - adipose, donor2	11748-123G2	57.44	6.91	3.82	1.27	0.55	0.18	0.36
mesenchymal precursor cell - adipose, donor3	11749-123G3	58.80	9.94	3.31	0.83	2.07	2.07	0.41
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	53.10	4.78	4.50	0.84	0.14	0.70	0.14
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	46.99	5.39	4.24	3.27	0.58	1.35	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	47.20	11.11	6.25	2.08	0.69	0.69	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	39.82	5.32	2.57	1.20	0.69	0.51	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	39.34	5.29	3.91	1.38	1.61	1.04	0.23
mesenchymal precursor cell - cardiac, donor3	11754-123G8	58.63	7.83	4.64	1.86	0.80	1.06	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	41.05	11.07	5.00	1.35	1.08	1.22	0.81
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	54.91	9.25	3.70	2.85	1.14	0.43	0.85
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	61.92	7.25	2.96	1.32	0.00	1.32	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	48.85	7.47	3.60	1.25	1.38	1.25	0.55
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	58.30	20.25	3.49	2.79	1.05	0.70	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	37.36	5.31	2.86	2.25	0.00	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	41.70	8.27	3.24	3.24	0.36	0.72	0.36
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	46.35	5.79	1.86	0.72	0.31	0.83	0.10
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	33.74	10.03	5.47	2.74	2.28	0.23	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	73.42	13.85	4.62	1.26	3.78	1.26	0.42
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	43.93	7.17	4.33	1.64	0.60	1.05	1.05
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	56.54	6.74	2.89	1.58	0.70	0.70	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	61.11	7.73	2.58	1.84	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	42.35	8.87	3.15	2.29	0.57	0.57	0.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	53.47	14.31	5.47	1.68	2.53	1.26	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	39.27	10.05	0.91	4.11	0.00	1.83	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	29.67	7.93	3.33	1.28	0.77	1.02	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	36.38	10.21	3.14	2.09	1.05	0.79	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	37.89	8.93	3.08	1.23	0.92	0.62	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	35.54	5.41	3.06	0.71	0.47	1.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	37.57	8.46	5.42	1.69	0.34	1.02	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	32.22	7.47	4.32	1.18	0.79	0.79	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	32.44	6.49	4.17	1.39	0.00	1.39	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	96.61	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	40.67	8.94	4.04	1.15	1.44	1.73	0.87
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	27.22	12.05	3.12	0.89	0.67	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	43.02	12.02	4.81	0.48	0.24	1.68	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	49.13	7.33	4.40	2.93	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	32.89	8.06	4.36	2.35	0.67	1.01	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	40.94	13.10	0.82	1.23	0.00	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	44.67	10.31	3.87	1.29	0.00	0.86	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	43.75	13.67	2.73	2.73	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	67.14	15.49	0.00	5.16	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	48.39	9.42	2.92	4.22	0.97	0.65	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	53.83	11.64	1.45	2.91	1.45	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	69.83	16.53	2.13	2.67	0.53	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	35.16	9.00	3.27	0.82	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	48.59	12.44	1.94	1.55	0.78	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	37.78	14.69	10.49	0.00	0.00	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	54.64	11.92	0.99	0.99	0.00	0.99	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	23.84	4.77	4.77	0.00	4.77	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	40.91	10.08	2.96	2.37	1.19	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	43.86	8.53	1.22	3.66	1.22	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	54.10	27.05	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	50.67	12.03	3.17	0.63	0.63	0.63	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	44.49	3.79	1.38	2.41	0.69	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	60.18	6.45	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	43.91	15.97	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	51.66	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	44.41	4.89	0.81	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	68.32	7.15	3.18	3.18	0.00	0.79	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	40.09	4.72	0.59	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	44.57	4.36	1.25	1.56	0.31	0.31	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	45.45	6.68	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	52.04	9.46	2.37	3.55	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	66.77	10.27	7.70	5.14	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	46.12	7.57	0.69	0.69	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	54.92	11.88	0.49	1.48	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	37.01	10.09	1.12	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	39.44	6.36	0.00	1.27	0.64	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	50.78	13.30	0.81	2.42	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	47.97	13.08	2.18	2.18	0.00	2.18	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	34.21	11.40	2.53	1.27	1.27	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	46.12	5.46	1.82	0.61	0.00	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	67.78	4.52	4.52	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	49.42	7.41	1.65	3.29	0.00	0.82	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	29.96	6.35	2.18	1.59	0.40	0.40	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	42.83	10.71	1.95	1.62	0.32	0.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	38.71	10.19	4.07	2.04	0.00	1.02	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	57.25	9.28	3.09	3.87	0.00	0.77	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	74.89	22.68	4.72	2.83	1.65	0.94	0.00
mesothelioma cell line:ACC-MESO-4	10494-107B8	83.40	18.77	10.43	3.48	6.95	1.85	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	102.57	8.55	8.55	4.27	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	64.94	11.61	7.81	1.34	3.39	0.92	0.31
mesothelioma cell line:Mero-25	10850-111F4	86.70	15.66	11.80	2.95	7.04	0.91	0.23
mesothelioma cell line:Mero-41	10851-111F5	71.63	27.87	9.78	6.11	1.71	0.98	0.49
mesothelioma cell line:Mero-48a	10852-111F6	53.14	15.28	4.21	1.77	1.99	1.33	0.66
mesothelioma cell line:Mero-82	10853-111F7	94.61	16.03	6.83	1.84	2.89	1.05	0.26
mesothelioma cell line:Mero-83	10854-111F8	84.77	22.13	4.77	3.23	1.70	0.85	0.85
mesothelioma cell line:Mero-84	10855-111F9	84.17	18.45	10.36	2.78	2.27	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	69.15	14.08	6.21	4.97	2.90	0.83	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	45.22	14.08	6.29	4.47	1.99	0.66	0.50
mesothelioma cell line:NCI-H226	10846-111E9	78.91	19.00	4.89	2.35	1.99	1.45	0.36
mesothelioma cell line:NCI-H2452	10848-111F2	88.66	25.79	12.81	4.61	2.22	1.88	0.34
mesothelioma cell line:NCI-H28	10845-111E8	44.28	12.72	8.40	3.05	2.54	1.02	0.25
mesothelioma cell line:No36	10857-111G2	77.64	16.64	10.11	3.26	3.26	0.33	0.65
mesothelioma cell line:ONE58	10858-111G3	49.86	17.07	5.15	1.90	3.25	1.35	0.27
migratory langerhans cells, donor1	11901-125F2	45.68	11.13	7.10	3.07	1.92	1.15	0.38
migratory langerhans cells, donor2	11902-125F3	34.44	9.77	5.37	2.69	1.34	0.37	0.24
migratory langerhans cells, donor3	11903-125F4	54.38	10.77	5.56	1.79	1.62	0.54	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	49.95	8.49	5.22	3.92	0.98	0.33	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	30.94	3.81	1.91	0.42	1.06	0.42	0.00
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	86.61	19.12	0.92	5.30	0.92	0.00	0.23
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	38.82	9.32	2.47	0.38	0.95	0.19	0.19
myelodysplastic syndrome cell line:SKM-1	10772-110F7	87.78	12.38	14.23	4.07	3.70	0.55	0.37
myeloma cell line:PCM6	10474-106I6	49.61	10.67	1.98	1.78	0.20	0.20	0.00
myxofibrosarcoma cell line:MFH-ino	10600-108E6	108.05	26.38	1.52	5.58	0.51	1.01	0.51
myxofibrosarcoma cell line:NMFH-1	10684-109E9	62.96	17.65	6.86	1.77	2.55	0.78	0.59
nasal epithelial cells, donor1, tech_rep1	12226-129F3	38.66	6.13	2.67	0.89	0.56	0.67	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	35.59	8.46	3.02	1.54	0.74	0.96	0.07
nasal epithelial cells, donor2	12227-129F4	30.91	13.25	3.31	1.66	1.10	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	209.13	9.66	5.52	1.84	1.38	0.69	0.23
neuroblastoma cell line:NB-1	10539-107G8	78.20	16.28	4.30	3.18	0.94	1.12	0.19
neuroblastoma cell line:NBsusSR	10607-108F4	117.25	9.49	6.54	1.90	2.11	0.42	0.42
neuroblastoma cell line:NH-12	10555-107I6	201.82	10.62	5.40	1.68	1.68	1.12	0.75
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	133.08	9.25	8.07	1.19	2.14	0.95	0.24
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	132.25	11.56	11.72	2.38	3.01	1.11	0.95
neuroectodermal tumor cell line:TASK1	10774-110F9	156.98	8.25	4.43	2.21	1.41	1.41	0.20
neuroepithelioma cell line:SK-N-MC	10728-110A8	176.11	28.61	5.09	1.27	0.00	1.27	0.64
neurofibroma cell line:Hs 53.T	10729-110A9	61.22	10.91	2.40	2.40	0.27	0.53	0.00
neutrophil PMN, donor1	12133-128D9	14.87	14.87	14.87	14.87	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	13.28	0.00	0.00	13.28	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	18.94	0.00	0.00	9.47	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	57.16	5.07	10.99	1.18	2.88	1.18	0.00
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	26.42	4.00	3.20	1.60	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	54.18	8.34	5.45	0.96	2.56	1.60	0.64
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	58.86	13.40	4.20	1.84	0.79	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	81.27	18.37	7.12	5.06	0.66	3.56	1.41
occipital cortex - adult, donor10196	10172-103C1	90.66	26.78	8.24	6.18	4.12	2.06	2.06
occipital cortex, adult, donor10252	10163-103B1	137.94	27.37	7.25	4.56	0.00	2.15	0.54
occipital cortex, newborn, donor10223	10355-105E4	119.37	28.39	5.46	6.91	9.83	0.73	0.00
occipital lobe, adult, donor1	10076-102A4	86.33	17.58	8.92	3.15	0.52	1.05	1.05
occipital lobe, fetal, donor1	10073-102A1	157.05	23.17	1.72	4.72	0.86	1.29	0.00
occipital pole, adult, pool1	10036-101E9	78.76	20.03	6.23	3.71	1.02	2.92	1.10
olfactory region, adult	10195-103E6	91.90	23.69	5.35	5.54	0.76	1.91	0.57
optic nerve, donor1	10277-104E7	90.05	26.01	4.00	12.01	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	47.16	11.50	3.42	1.14	0.68	0.91	0.11
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	40.12	5.08	10.85	0.82	3.85	0.96	0.27
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	56.89	10.33	3.22	2.37	0.51	0.17	0.17
oral squamous cell carcinoma cell line:SAS	10544-107H4	39.16	7.28	3.23	2.31	0.46	0.35	0.00
osteoclastoma cell line:Hs 706.T	10704-109H2	47.62	8.82	2.94	2.06	0.59	0.59	0.59
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	85.96	15.88	2.80	6.54	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	60.01	9.75	4.24	2.97	2.12	0.85	0.21
ovary, adult, pool1	10020-101D2	75.56	8.04	8.21	2.10	0.44	1.48	0.44
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	90.01	14.67	1.47	1.65	0.55	0.37	0.00
pancreas, adult, donor1	10049-101G4	119.46	4.70	0.94	0.94	0.94	0.00	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	83.02	8.39	0.84	0.28	0.00	0.00	0.28
papillary adenocarcinoma cell line:8505C	10437-106E5	40.54	9.03	6.98	3.24	1.19	0.68	0.17
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	42.06	5.80	3.15	0.83	1.49	0.33	0.00
paracentral gyrus, adult, pool1	10035-101E8	74.87	21.69	8.24	3.94	2.11	3.39	0.92
parietal cortex, adult, donor10258	10373-105G4	84.41	27.16	6.61	2.20	0.00	3.67	1.47
parietal lobe - adult, donor10196	10171-103B9	73.36	24.45	0.94	2.82	3.76	0.94	1.88
parietal lobe, adult, donor10252	10157-103A4	141.09	27.08	7.70	5.13	0.57	1.71	0.00
parietal lobe, adult, pool1	10034-101E7	85.21	21.68	8.02	3.61	1.59	3.35	1.50
parietal lobe, fetal, donor1	10072-101I9	119.29	9.70	0.97	4.85	0.97	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	102.81	26.17	6.36	6.73	8.60	0.75	0.00
parotid gland, adult	10199-103F1	49.95	9.87	1.23	3.08	0.00	0.00	0.00
penis, adult	10200-103F2	59.62	10.74	3.76	2.69	1.61	0.00	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	132.39	25.29	10.60	6.51	1.67	0.74	1.86
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	93.24	19.67	5.39	3.93	2.04	1.17	0.29
pineal gland - adult, donor10196	10179-103C8	66.44	14.84	1.94	3.23	0.00	0.65	1.94
pineal gland, adult, donor10252	10160-103A7	106.01	14.81	8.88	4.74	1.18	2.96	0.59
pineal gland, adult, donor10258	10377-105G8	92.81	20.07	6.27	5.02	0.63	2.51	1.25
pituitary gland - adult, donor10196	10180-103C9	107.25	23.27	11.13	2.02	1.01	1.01	4.05
pituitary gland, adult, donor10252	10162-103A9	174.60	31.27	14.59	6.78	1.04	3.65	1.04
pituitary gland, adult, donor10258	10378-105G9	146.41	24.69	5.96	1.70	0.85	2.55	0.00
placenta, adult, pool1	10021-101D3	34.19	9.68	3.01	2.47	0.22	0.43	0.22
plasma cell leukemia cell line:ARH-77	10840-111E3	64.09	9.01	6.62	1.99	4.24	0.79	0.00
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	28.17	6.07	3.11	1.25	0.62	0.31	0.16
pons, adult, pool1	10033-101E6	57.49	13.34	5.51	2.75	1.55	1.89	1.20
postcentral gyrus, adult, pool1	10032-101E5	83.43	23.01	9.76	3.84	1.05	3.31	1.31
promyelocytes/myelocytes PMC, donor1	12132-128D8	46.01	10.46	6.27	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	33.05	27.54	0.00	0.00	5.51	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	11.74	11.74	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	77.78	20.39	4.52	2.77	2.04	1.02	0.87
prostate cancer cell line:PC-3	10439-106E7	123.24	37.57	8.17	6.17	1.27	1.82	0.54
prostate, adult, pool1	10022-101D4	75.46	6.71	3.17	1.45	0.36	1.09	0.27
putamen, adult, donor10196	10176-103C5	85.46	28.56	9.21	6.61	2.12	3.54	1.42
putamen, adult, donor10252	10152-102I8	78.43	9.80	3.92	1.96	0.00	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	52.45	30.60	7.65	0.00	2.19	0.00	3.28
putamen, adult, donor10258, tech_rep2	10372-105G3	77.56	19.09	6.28	3.87	0.48	4.11	0.72
putamen, newborn, donor10223	10365-105F5	80.96	22.49	13.49	3.75	10.50	3.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	77.97	14.26	4.65	3.49	2.33	0.58	0.29
rectum, fetal, donor1	10067-101I4	130.75	12.52	2.78	6.95	1.39	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	48.76	13.78	10.81	1.91	2.97	2.76	0.21
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	39.76	7.87	2.07	1.66	0.83	0.00	0.41
retina, adult, pool1	10030-101E3	75.25	14.21	5.77	2.19	0.50	1.69	0.50
retinoblastoma cell line:Y79	10475-106I7	194.07	13.77	6.75	1.56	0.26	2.08	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	68.36	10.45	4.67	2.09	1.72	1.11	0.61
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	69.18	4.22	5.91	1.69	0.84	1.69	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	121.26	11.37	1.52	1.52	0.00	0.00	0.76
salivary acinar cells, donor1	11771-123I7	80.28	7.45	3.72	0.81	0.32	0.16	1.13
salivary acinar cells, donor2	11772-123I8	71.87	8.12	3.30	1.65	0.83	0.83	0.14
salivary acinar cells, donor3	11773-123I9	118.51	7.94	1.99	1.32	0.00	0.66	0.00
salivary gland, adult, pool1	10093-102C3	84.08	7.44	3.43	2.29	1.14	1.14	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	83.22	16.36	8.18	4.22	0.76	1.52	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	89.93	18.81	7.76	4.58	0.82	1.76	0.59
seminal vesicle, adult	10201-103F3	72.48	8.99	6.35	2.65	0.00	0.00	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	67.53	11.42	5.83	2.92	3.16	0.97	0.00
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	52.84	12.08	12.08	2.77	4.28	0.75	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	98.35	19.07	17.06	4.01	3.01	3.01	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	38.28	8.33	5.51	1.88	2.15	1.21	0.54
signet ring carcinoma cell line:Kato III	10436-106E4	24.21	4.53	0.66	0.99	0.33	0.00	0.00
signet ring carcinoma cell line:NUGC-4	10483-107A6	59.74	11.87	3.10	1.42	0.52	1.03	0.26
skeletal muscle - soleus muscle, donor1	10282-104F3	49.65	9.93	0.71	1.42	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	48.57	6.60	1.68	1.44	0.24	0.12	0.24
skeletal muscle, fetal, donor1	10066-101I3	116.58	9.05	4.02	5.03	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	33.93	13.57	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	56.18	7.57	3.16	3.79	0.63	0.00	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	53.70	7.67	3.00	0.67	2.33	0.33	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	156.66	14.50	3.78	2.21	2.84	0.95	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	73.63	12.91	3.28	2.70	3.66	0.58	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	94.61	10.55	4.12	0.99	1.15	0.33	0.16
small cell lung carcinoma cell line:NCI-H82	10842-111E5	84.12	6.76	5.31	1.77	0.97	1.13	0.48
small cell lung carcinoma cell line:WA-hT	10562-108A4	62.98	12.42	1.96	2.83	0.44	0.22	0.22
small intestine, adult, pool1	10024-101D6	80.27	16.12	3.22	3.94	0.96	1.31	0.00
small intestine, fetal, donor1	10064-101I1	103.93	12.78	5.16	2.21	1.23	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	179.52	24.62	10.77	9.23	4.62	0.51	0.51
smooth muscle, adult, pool1	10048-101G3	65.39	10.86	3.62	2.33	0.26	0.78	0.00
somatostatinoma cell line:QGP-1	10781-110G7	101.85	14.74	3.22	2.95	0.54	0.54	0.27
spinal cord - adult, donor10196	10181-103D1	102.77	16.75	2.29	6.88	1.15	0.92	0.00
spinal cord, adult, donor10252	10159-103A6	76.09	13.01	2.37	3.55	0.00	0.39	0.00
spinal cord, adult, donor10258	10369-105F9	59.49	20.75	6.23	6.23	0.69	0.00	1.38
spinal cord, fetal, donor1	10056-101H2	89.04	15.25	7.32	3.05	1.83	0.00	0.00
spinal cord, newborn, donor10223	10359-105E8	82.66	18.37	5.97	2.76	2.30	2.30	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	56.46	12.25	1.34	2.24	0.60	0.30	0.15
spleen, adult, pool1	10025-101D7	68.94	10.02	2.20	2.09	0.77	0.88	0.00
spleen, fetal, pool1	10044-101F8	68.81	7.15	4.05	1.99	0.72	0.72	0.16
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	75.25	14.70	6.83	2.90	2.17	1.04	0.83
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	70.25	15.76	4.18	2.85	1.14	0.00	0.00
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	49.62	10.48	1.40	2.45	1.40	1.05	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	151.68	30.88	4.69	4.69	1.95	0.78	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	74.51	23.41	10.58	5.85	3.04	2.03	0.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	63.54	18.64	10.17	2.12	3.39	0.85	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	53.73	11.85	2.12	3.38	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	106.80	21.36	0.00	7.48	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	56.40	3.99	5.13	0.00	0.00	1.14	1.14
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	55.25	13.71	7.89	1.45	1.25	0.62	0.42
substantia nigra, adult, donor10258	10371-105G2	53.79	22.24	5.17	4.66	0.52	1.55	1.55
substantia nigra, newborn, donor10223	10358-105E7	91.15	21.20	2.83	7.77	1.41	0.71	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	103.40	18.57	7.34	3.90	2.06	1.15	0.69
temporal lobe, adult, pool1	10031-101E4	87.91	19.50	9.92	4.75	1.61	3.81	0.93
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	123.93	16.38	5.70	4.99	0.71	2.14	0.71
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	102.41	16.70	3.96	4.83	0.88	1.76	0.88
tenocyte, donor1	11763-123H8	39.10	12.22	3.84	1.75	2.44	0.70	0.35
tenocyte, donor2	11765-123I1	51.88	6.10	3.05	3.43	0.38	0.38	0.00
tenocyte, donor3	11768-123I4	31.88	11.86	4.82	2.22	0.00	0.74	0.74
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	109.79	5.78	1.70	1.02	1.19	0.51	0.51
teratocarcinoma cell line:NCR-G1	10798-110I6	76.61	4.93	3.24	1.08	0.62	0.77	0.31
teratocarcinoma cell line:PA-1	10807-111A6	43.24	1.24	2.01	0.62	0.46	0.31	0.31
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	48.75	5.08	2.79	1.14	0.76	0.38	0.25
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	97.57	9.08	4.16	1.51	1.13	0.76	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	103.83	4.91	0.98	1.53	1.74	0.11	0.00
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	87.94	7.49	10.42	1.95	6.19	0.33	1.30
testis, adult, pool1	10026-101D8	64.10	17.50	7.41	3.33	1.61	4.19	5.26
testis, adult, pool2	10096-102C6	101.04	50.52	22.10	6.77	4.06	9.02	14.43
thalamus - adult, donor10196	10168-103B6	68.45	18.77	2.21	4.42	1.10	1.10	0.00
thalamus, adult, donor10252	10154-103A1	80.80	14.69	5.16	3.91	2.03	0.78	0.47
thalamus, adult, donor10258, tech_rep1	10370-105G1	60.05	66.20	10.78	1.54	1.54	0.00	4.62
thalamus, adult, donor10258, tech_rep2	10370-105G1	56.82	15.65	3.13	1.98	0.16	0.49	0.16
thalamus, newborn, donor10223	10366-105F6	70.76	23.59	8.05	4.03	8.05	0.58	0.00
throat, adult	10209-103G2	48.19	11.98	3.25	2.75	0.50	0.50	0.00
throat, fetal, donor1	10061-101H7	82.58	10.66	3.66	1.83	0.91	1.52	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	136.53	12.92	6.16	1.19	1.79	0.79	0.60
thymus, adult, pool1	10027-101D9	64.32	6.26	12.82	1.59	1.89	1.69	0.20
thymus, fetal, pool1	10043-101F7	74.60	8.83	5.71	1.66	1.97	0.94	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	48.93	9.71	5.32	1.73	2.13	0.66	0.40
thyroid carcinoma cell line:TCO-1	10783-110G9	87.73	19.84	2.65	5.31	1.68	0.42	0.42
thyroid, adult, pool1	10028-101E1	106.84	13.34	7.28	2.71	0.37	1.03	0.28
thyroid, fetal, donor1	10060-101H6	52.47	12.39	5.01	4.75	0.26	1.05	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	95.47	30.80	0.00	6.16	0.00	0.00	0.00
tongue, adult	10203-103F5	43.96	8.84	4.42	2.56	0.47	0.47	0.23
tongue, fetal, donor1	10059-101H5	66.60	9.06	3.15	3.15	0.39	0.39	0.39
tonsil, adult, pool1	10047-101G2	71.63	14.83	4.01	2.60	0.90	1.00	0.00
trachea, adult, pool1	10029-101E2	58.40	11.53	5.73	2.54	1.06	1.55	0.16
trachea, fetal, donor1	10058-101H4	75.40	9.23	3.46	2.69	0.77	1.54	0.38
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	69.08	10.98	4.61	2.13	2.13	1.06	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	52.89	9.22	6.38	2.13	1.01	1.72	0.30
transitional-cell carcinoma cell line:JMSU1	10492-107B6	128.95	21.15	4.54	5.01	1.10	0.94	0.47
tridermal teratoma cell line:HGRT	10694-109G1	224.50	26.64	1.90	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	46.73	11.17	2.12	1.35	0.17	0.59	0.34
umbilical cord, fetal, donor1	10057-101H3	64.68	2.09	2.09	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	111.42	9.73	6.31	2.22	1.02	1.02	0.68
uterus, fetal, donor1	10055-101H1	92.66	8.70	6.14	1.02	0.00	1.54	0.51
vagina, adult	10204-103F6	109.85	4.52	2.58	3.23	0.00	0.65	0.00
vein, adult	10191-103E2	65.54	7.45	4.82	1.32	0.44	0.00	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	57.95	9.08	2.40	2.94	2.14	0.27	0.80